author index for volume 41 - core · author index for volume 41 aakhus s (abst) 507 abboud he:...

Author Index For Volume 41

Aakhus S (abst) 507Abboud HE: Platelet-derived growth factor and mesan-

gial cells 581Abe K See Ogahara S et al 175Abraham WT See Hensen J et al 1333Abramovici M See Singhal PC et al 1560Abrass CK (abst) 705Adams S See Vlahakos DV et at 1690Adcox MJ (abst) 705Adler SG (abst) 700, 705Adler SG See Ihm C-G et al 768Aeo G (abst) 1463Ahlstrand C (abst) 510Ahn CI (abst) 1453AhnDW(abst) 1451Ahn JH (abst) 1449, 1449, 1452, 1454, 1456, 1462Ahn SH (abst) 1465Ahn Si (abst) 1448, 1465Ahonen J See Isoniemi HM et a! 155Airaghi C (abst) 1441AkarU(abst) 1472Akbay E (abst) 1470Akçay G (abst) 1473Akoglu E (abst) 1470Akoglu T (abst) 1470Akpolat T (abst) 1470Akyazici P (abst) 1471Alarabi AA (abst) 501Alaupovic P (abst) 499Albers C (abst) 488Albini F See Parati G et a! 37:S-24Alexiewicz JM See Chervu I et al 1501Alinovi R See Khalil-Manesh F et al 1192A1-Khateeb M See Said R et a! 414Alkim H (abst) 1472Allan PL See Watson ML et al 206Allegra A (abst) 1444Allemann Y (abst) 481Allen T See Jerurns G et al 904Allen Ti See Cooper ME et a! 898Almeida ARP, Wetzels JFM, Bunnachak D, Burke Ti,

Chairnovitz C, Hammond WS, Schrier RW: Acutephosphate depletion and in vitro rat proximal tubuleinjury: Protection by glycine and acidosis 1494

Aloisi C (abst) 1444Alpdogan O (abst) 1470Alpers CE (abst) 701Alpers CE, Hudkins KL, Gown AM, Johnson RJ: En-

hanced expression of "muscle-specific" actin inglomerulonephritis 1134

Alpers CE See Floege J et al 297Altrnann J-J See Mal F et al 445A1-Uzri A, Holliday MA, Gambertoglio JG, Schambe-

lan M, Kogan BA, Don BR: An accurate practicalmethod for estimating GFR in clinical studies using aconstant subcutaneous infusion (Technical Note) 1701

Alvarez Ri, Sun Mi, Haverty TP, lozzo RV, MyersJC, Neilson EG: Biosynthetic and proliferative char-acteristics of tubulointerstitial fibroblasts probed withparacrine cytokines 14

Ambroso G (abst) 1446Amento E (abst) 696Arnie! C See Bailly C et a! 269Amieva M See Furthmayr H et at 665Ammer U (abst) 478Amrani A See Baud L et al 600An SJ (abst) 1455, 1464, 1464Ancarani P (abst) 1446Andersen CB (abst) 508Andersen HK (abst) 510Andersen NF (abst) 505Andersen T (abst) 513Anderson A See Morgan TO et al 36:S-78Anderson PH See Hansen KW et al 847Anderson PS (abst) 700Anderson S, Rennke HG, Brenner BM, Zayas MA,

Lafferty HM, Troy JL, Sandstrom Di: Nifedipineversus fosinopril in uninephrectomized diabeticrats 891

Andrassy K (abst) 478, 488, 490, 700Andreoli TE: Kidney International: Perspectives from

the editors 1

Angielski S (abst) 494Angus iA, Dyke AC, Jennings GL, Korner P1, Sudhir

K, Ward iE, Wright CE: Receptor-stimulated releaseof endothelium-derived relaxing factor from resis-tance arteries in hypertension 37:S-73

Angus JA See Korner PT et al 37:S-38Anidjar S, Osborne-Pellegrin M, Coutard M,

Michel J-B: Arterial hypertension and aneurysmaldilatation 37:S-61

Antonucci F (abst) 1443Apak H (abst) 1467Apenberg S (abst) 478Apperloo AJ (abst) 1436Arakawa K See Ogahara S et a! 175Arakawa M See Hayashi H et al 749Ardaillou N See Stefanovië V et a! 1571Ardaillou R (abst) 480Ardaillou R, Bens M, Edgington TS: Glomerular tissue

factor stimulates thromboxane synthesis in humanplatelets via thrombin generation 361

Ardaillou R See Stefanovië V et al 1571Argiles A See Kerr PG et a! 1035Arik N (abst) 1469, 1470, 1471, 1472Arinsoy I (abst) 1469, 1470, 1471, 1472Arisoy E (abst) 1469Arisoy N (abst) 1467Arisoy S (abst) . 1469Arisz L (abst) 1433, 1436, 1437, 1437Arisz L See Struijk DG et a! 1668Ark E(abst) 1466, 1473Armelloni S (abst) 697Arminio A See Muller GY et al 1055

1749

1750 Author index: Vol. 41

Arnolda L, Minson J, Kapoor V, Pilowsky P,Liewellyn-Smith I, Chalmers J: Amino acid neuro-transmitters in hypertension 37:S-2

Aronson PS (abst) 485Arslan N (abst) 1469Arsian S (abst) 1470Artishevsky A (abst) 700, 705Artishevsky A See Ihm C-G et a! 768Asmus 0 (abst) 488Assmann KJM (abst) 1430, 1432Assmann KJM See van den Born J et a! 115Ataman R (abst) 1466, 1466, 1467Attawia MA See Nayak RC et a! 1638Attman P.O (abst) 499Aulmann G (abst) 492Aunsholt NA (abst) 506Aurell M (abst) 500, 512, 512Aurell M, Björck S: Determinants of progressive renal

disease in diabetes mellitus 36:S-38Austin HA See Choyke PL et a! 1595Avogaro A See Trevisan R et a! 855Avsar T (abst) 1473Ayaz M (abst) 1466, 1466Ayaz S (abst) 1470Aydin AE (abst) 1471Aykaç B (abst) 1467Aynedjian HS See Wilkes BM et al 992Ayo SH (abst) 700Aysuna N (abst) 1466, 1467, 1473Bach D (abst) 485Bachman S, Peters J, Engler E, Ganten D, Mullins J:

Transgenic rats carrying the mouse renin gene—Mor-phological characterization of a low-renin hyperten-sion model 24

Bachmann S (abst) 478, 496Backman U (abst) 507, 512Badalamenti S (abst) 1446Badr KF See Fischer DB et al 1155Badr KF See Takahashi K et al 1245Bae HM (abst) 1462Bae HY (abst) 1463Baelde JJ (abst) 700Bagni B (abst) 1441, 1443Bahner U (abst) 482Baier LD See Tilton RG et al 778Bailey J See May RC et al 1535Bailly C, Bartlet-Bas C, Amiel C: Platelet activating

factor inhibits Cl and K transport in the medullarythick ascending limb 269

Bak M See Barzilay .1 et al 723Bakan E (abst) 1472Bakkaloglu A (abst) 1470, 1470Bakker MAH See van den Born J et al 115Bakris GL, Barnhill BW, Sadler R: Treatment of arte-

rial hypertension in diabetic humans: Importance oftherapeutic selection 912

Balat A (abst) 1468Baldari S (abst) 1444Ballardie FW See Brenchley PE et al 933Balimer PE, Weber BK, Roy-Chaudhury P, McNurlan

MA, Watson H, Power DA, Garlick PJ: Elevation ofalbumin synthesis rates in nephrotic patients mea-sured with l1-'3C]leucine 132

Bang BK (abst) 1448, 1455, 1457, 1460, 1460, 1463,1464, 1464, 1464, 1464, 1464, 1465

Bang DS (abst) 1456

Bangstad H-J (abst) 703Bangstad HJ See Dahl-JØrgensen K et al 920Bank N See Wilkes BM et a! 992Baranowski RL (abst) 699Bárány P (abst) 503, 504, 504, 505Bardelli M (abst) 512Barfuss DW, McCann WP, Katholi RE: Axial heteroge-

neity of adenosine transport and metabolism in therabbit proximal tubule 1143

Barkeling B (abst) 503Barnhill BW See Bakris GL et al 912Barrès C, Julien C, Sassard J: Arterial pressure control

in the sympathectomized rat 37:S-19Barrett BJ, Parfrey PS, Vavasour HM, McDonald J,

Kent G, Hefferton D, O'Dea F, Stone E, Reddy R,McManamon PJ: Contrast nephropathy in patientswith impaired renal function: High versus low osmo-lar media 1274

Barrett GL, Mullins JJ: Studies on blood pressure regu-lation in hypertensive ren-2 transgenic rats 37:S-125

Barrett KJ See Vlahakos DV et al 1690Bartel C (abst) 478Bartlet-Bas C See Bailly C et al 269Barzilay J, Warram JH, Bak M, Laffel LMB, Canessa

M, Krolewski AS: Predisposition to hypertension:Risk factor nephropathy and hypertension inIDDM 723

Basler V (abst) 1445Batile DC See Nutting CW et al 166Batsford S (abst) 495Batur N (abst) 1468Baud L (abst) 698Baud L, Fouqueray B, Philippe C, Amrani A: Tumor

necrosis factor alpha and mesangial cells 600Baudoin P (abst) 1437Baum RP (abst) 492Baumann K (abst) 484Bäumer K (abst) 482Baumgart P (abst) 478Baumgartner S (abst) 701Bazzi C (abst) 1445Beaugrand M See Ma! F et a! 445Beck FX (abst) 494Beck-Gessert S (abst) 705Beckman JK See Yoshioka T et al 1008BedaniPL(abst) 1441, 1443Behrend M (abst) 484Beilin U: Dietary salt and risk factors for cardiovascu-

lar disease 37:S-90Beksac M (abst) 1468, 1470Bennett R See Hogg N et al 613Bens M See Ardai!lou R et al 361Benstein JA See Lax DS et a! 1527Berardinelli L (abst) 1439Berdeaux A, Duranteau J, Pussard E, Edouard A, Giu—

dicelli J-F: Baroreflex control of regional vascularresistances during simulated orthostatism 37:S-29

Berden JHM (abst) 1432Berden JHM See Elving LD et al 862Berden JHM See van den Born J et a! 115Berg KJ (abst) 500, 507, 703Berg U (abst) 512Bergamaschi E See Khalil-Manesh F et a! 1192Berger B (abst) 496Bergijk EC (abst) 700Bergijk EC See Bruijn JA et a! S

Author Index: Vol. 41 1751

Bergstrand A (abst) 507, 511, 511Bergstrom J (abst) 501, 503Bergstrom J See Canepa A et a! 1016Ben T, Mansour J, Veis JH: Regulation of atrial natri-

uretic peptide-stimulated cGMP production in the in-ner medulla 37

Bernasconi P (abst) 697Berney T See Lemoine R et al 65Berto P See Ronco C et a! 1383Bertocchi C See Gaspari F et a! 1081Bertolissi M (abst) 1443Beba N (abst) 1470, 1470Bettini MC See Ronco C et a! 1383Betz M (abst) 486Beuve CS, Leclercq C, Rannou F, Oliviero P, Mansier

P, Chevalier B, Swynghedauw B, Charlemagne D:Remodeling of the heart (membrane proteins and col-lagen) in hypertensive cardiopathy 37:S-45

Bianco NE See Muller GY et a! 1055Bianco P See Kopp JB et al 56Bichara M See Houillier P et al 1182Biel K (abst) 493Bieneck S (abst) 494Bilgel H (abst) 1473Bindels RIM (abst) 1434Binswanger U (abst) 491Birgegârd G (abst) 507BjOrck S See Aurell M et a! 36:S-38BjØro T See Dahl-JØrgensen K et al 920Blankenstijn PJ (abst) 1437Blaser C (abst) 479, 498Bleck J (abst) 487Blin P See Ramboer I et al 37:S-67Blumberg A, Weidmann P, Ferrari P: Effect of pro-

longed bicarbonate administration on plasma potas-sium in terminal renal failure 369

Bobik A See Korner P1 et al 37:S-38Bock HA (abst) 498Bock HA, Herm!e M, Brunner FP, Thiel G: Pressure

dependent modulation of renin release in isolated per-fused glomeruli 275

Bocker G (abst) 1434Boeckmann W (abst) 492Boer K (abst) 1437BoerP(abst) 1430, 1435Boer WH (abst) 1430BoeroR(abst) 1442, 1442Boes A (abst) 702Boes A See Wolthuis A Ct al 124Bogman MJJT (abst) 1430Bognetti E See Jones SL et al 1620Bohie A (abst) 484BOhler J (abst) 479Bohman S-O (abst) 512Boland R (abst) 479Bollen C (abst) 479Bonanno N (abst) 1444Bonara P (abst) 1439Bonilla-Felix M, Hamm LL, Herndon J, Vehaskari

VM: Response of cortical collecting ducts from rem-nant kidneys to arginine vasopressin 1150

Bonj our J-P See Pedrotti A et al 80Borch-Johnsen K, NØrgaard K, Hommel E, Mathiesen

ER, Jensen JS, Deckert T, Parving H-H: Is diabeticnephropathy an inherited complication9 719

Border WA, Noble NA, Yamamoto T, Tomooka S, Ka-gami S: Antagonists of transforming growth factor-/3:A novel approach to treatment of glomerulonephritisand prevention of glomeruloscierosis 566

Border WA See Nakamura T et a! 1213Borensztein P See Houillier P et al 1182Borgatti PP (abst) 1441Boss C (abst) 495Bostad L See HoIm J et al 50Bostedt A (abst) 484Bottomly K (abst) 705Bourgoignie JJ: Progression of renal disease: Current

concepts and therapeutic approaches 36:S-6lBourgoignie JJ See Green DF et a! 956Bourgoignie JJ See Green DF et al 1506Bovio G (abst) 1443Bowen-Pope DF See Floege J et a! 297Bowen-Pope DF See Johnson R et al 590Bozfakioglu S (abst) 1466, 1467, 1473Bozkirli I (abst) 1473Brancaccio D (abst) 1443Brandi L (abst) 501, 502Brändle E (abst) 478, 479BrännstrOm M (abst) 502Brass EP See Hiatt WR et a! 1613Breborowicz A, Rodela H, Oreopoulos DG: Toxicity

of osmotic solutes on human mesothelial cellsin vitro 1280

Brecht U (abst) 491, 495Bred! CR See Zager RA et a! 1588Brenchley PE, Coupes B, Short CD, O'Donoghue DJ,

Ballardie FW, Mallick NP: Urinary C3dg and C5b-9indicate active immune disease in human membra-nous nephropathy 933

Brendolan A See Ronco C et a! 1383Brenner BM See Anderson S et a! 891Bretzel RG (abst) 479Breyer MD See Takeda M et al 1713Brickner ME See Levy FL et a! 961Briner VA (abst) 699Briscoe DM See Ford DM et al 1606Broe MED See Vasilakakis DM et a! 1400Bronzieri C (abst) 1443Brown R (abst) 704Brown Z (abst) 695Brown!ee AA See Esnault VLM et a! 1304Brownlee M See Gupta S et a! 1161Brubacher D (abst) 701Bruijn JA (abst) 700, 1431, 1432, 1432Bruijn JA, Bergijk EC, de Heer E, Fleuren GJ, Hoede-

maeker PJ: Induction and progression of experimen-tal lupus nephritis: Exploration of a pathogenic path-way (Editorial Review) 5

Bruining G (abst) 1437Brunette MG, Mailloux J, Lajeunesse D: Calcium trans-

port by the luminal membrane of distal tubule. II.Effect of pH, electrical potential and calcium channelinhibitors 289

Brunette MG, Mailloux J, Lajeunesse D: Calcium trans-port through the luminal membrane of the distal tu-bule. I. Interrelationship with sodium 281

Brunner FP (abst) 498Brunner FP See Bock HA et a! 275Brussel EMM-V See Freyss-Beguin MM et al 37:S-79Buch S (abst) 701Bucht H (abst) 511, 511

1752 Author Index: Vol. 41

Buemi AL (abst) 1444Buemi M (abst) 1444Buhi M (abst) 696Bunnachak D See Almeida ARP et a! 1494Buoncristiani U (abst) 1440Burke TJ See Almeida ARP et a! 1494Burns A See Spencer SJW et al 1059Burns M (abst) 701Burns MW See Floege J et al 297Busse R (abst) 697Butcher EC (abst) 696Buur T (abst) 502Buyan N (abst) 1473Buyssens N (abst) 1435Byun HJ (abst) 1459Byun HY (abst) 1456Cabanas C See Hogg N et a! 613caglar S (abst) 1472ca1ar (abst) 1469, 1470, 1471Caglioti A See Canton AD et a! 951Cahill CJ See Nayak RC et al 1638Calemard E See Charra B et al 1286Ca1ikan S (abst) 1467, 1467Callard P See Mat F et al 445Cab L (abst) 1443Calvet JP See Harding MA et a! 317Calvisi L (abst) 1447Campbell HT See Rouch AJ et a! 342Canaud B See Kerr PG et al 1035Canavese C (abst) 1447Canepa A, Filho JCD, Forsberg A-M, Perfumo F, Car-

rea A, Gusmano R, Bergstrom J: Nutritional statusand muscle amino acids in children with end-stagerenal failure 1016

Canessa M See Barzilay J et a! 723Cantaluppi A (abst) 1441Canton AD, Fujano G, Sepe V, Caglioti A, Ferrone S:

Mesangial expression of intercellular adhesion mole-cule- 1 in primary glomerulosclerosis 951

Capasso G (abst) 1444Capriles FT See Muller GY et al 1055Caramelo C (abst) 695Carbonell ME See Fermindez JM et al 1029Carin M (abst) 1467, 1471, 1472Carlsson MS (abst) 510Carmines PK, Mitchell KD, Navar LG: Effects of cal-

cium antagonists on renal hemodynamics and glomer-ular function 36:S-43

Carozzi S (abst) 1441Carrea A See Canepa A et a! 1016Carroll HJ (abst) 1450Casado S (abst) 695Casati S (abst) 1446Cavallini AR (abst) 1441Cederhoim B (abst) 509Cedgárd S (abst) 510celiker H (abst) 1469Cerrahpaa IU (abst) 1467cetin S (abst) 1468Cha DR (abst) 1455, 1459ChaFJK(abst) 1459Cha Yl (abst) 1455Chae DW (abst) 1450, 1452Chai KX See Jaffa AA et a! 789Chaimovitz C See Almeida ARP et a! 1494Chalmers J See Arnolda L et a! 37:S-2

Chalmers JP See Elghozi J-L et al 37:S-lChan JCM See Santos F et at 356Chana RS (abst) 699Chang K See Ido Y et a! 435Chang KS (abst) 1450Chang YS (abst) 1448, 1455, 1457, 1464, 1464, 1465Chansel D (abst) 480Chao J See Jaffa AA et al 789Chao L See Jaffa AA et a! 789Charlemagne D See Beuve CS et a! 37:S-45Charra B, Calemard E, Ruffet M, Chazot C, Torrat J-C,

Vanel T, Laurent G: Survival as an index of ade-quacy of dialysis 1286

Chazot C See Charra B et a! 1286Chen Y See Rocco MV et a! 107Chensue SW See Schmouder RL et al 191Cheon RH (abst) 1450Cheong HI (abst) 1454Cheong HI See Kieppel MM et al 1629Cherchi G (abst) 1447Chervu I, Kiersztejn M, Alexiewicz JM, Fadda GZ,

Smogorzewski M, Massry SG: Impaired phagocytosisin chronic renal failure is mediated by secondaryhyperparathyroidism 1501

Cheuñg AHS, Sutherland DER, Gillingham KJ,McHugh LE, Moudry-Munns KC, Dunn DL, Najar-ian JS, Matas AJ: Simultaneous pancreas-kidneytransplant versus kidney transplant alone in diabeticpatients 924

Chevalier B See Beuve CS et a! 37:S-45Chi JG (abst) 1453Chintala MS, Jandhyala BS: Evaluation of the efficacy

of felodipine in two models of acute renal failure indogs 36:S-94

Chiquet M (abst) 701Chiquet M: Tenascin: An extracellular matrix protein

involved in morphogenesis of epithelial organs 629Cho BS (abst) 1453Ch0DK(abst) 1457, 1462Cho iT (abst) 1460Ch0KB(abst) 1461Cho KW (abst) 1451Cho SW (abst) 1455Cho WH (abst) 1460Cho WY (abst) 1452, 1455, 1459Choi EJ (abst) 1455Choi HJ (abst) 1461Choi IJ (abst) 1453, 1453, 1463Choi iS (abst) 1461Choi KC (abst) 1451Choi KH (abst) 1448, 1450, 1456, 1458, 1459,

1462, 1463, 1463Choi SD (abst) 1463Choi Y (abst) 1454, 1461Cholmakow K (abst) 483Choyke PL, Austin HA, Frank JA, Girton ME,

Diggs RL, Dwyer AJ, Miller LG, Nussenblatt R,McFarland H, Simon T: Hydrated clearance ofgadolinium-DTPA as a measurement of g!omerularfiltration rate 1595

Christensen A-L (abst) 503Christensen CK See Hansen KW et al 847Christensen CK See Pederson MM et al 883Christians U (abst) 487Christiansen JS See Hansen KW et a! 847Christman JW See Fischer DB et a! 1155


Chu KU (abst) 1460Chun RW (abst) 1452Chung CH (abst) 1450Chung SH (abst) 1459Chung TH (abst) 1453, 1457Chung WY (abst) 1452Chung Y (abst) 1454Ciceri R (abst) 1446ciftcioglu MA (abst) 1473Cinotti GA (abst) 1442Cinotti GA See Menè P et al 554Cinquegrani M (abst) 1444Cintin C (abst) 503Cipollina MR See Trevisan R et al 855Ciresi DL, Lloyd MA, Sandberg SM, Heublein DM,

Edwards BS: The sodium retaining effects ofcyclosporine 1599

timan B (abst) 695Claesson-Welsh L See Heldin C-H et al 571Clement J (abst) 1431Cloarec-Blanchard L, Girard A, Houhou S. GrUnfeld

J-P, Elghozi J-L: Spectral analysis of short-termblood pressure and heart rate variability in uremicpatients 37:S-14

Close CF See Walker JD et al 741Clyne N (abst) 504, 504Coe FL, Parks JH, Webb DR: Stone-forming potential

of milk or calcium-fortified orange juice in idiopathichypercalciuric adults 139

Coers W (abst) 1432Cofano F (abst) 1446Coffman TM See Smith SR et al 199Coffman TM See Spurney RF et a! 973Cogno C (abst) 1439Cohen AH See Khalil-Manesh F et al 1192Cohen DI (abst) 483Cohen Tervaert JW (abst) 1435coker M (abst) 1468Colantonio G (abst) 1443Coleman DL (abst) 698Coleman DL, Ruef C: Interleukin-6: An autocrine regu-

lator of mesangial cell growth 604Collins DM, Lambert MB, Middleton JP, Proctor RK,

Davidson Ci, Newman GE, Schwab SJ: Fistula dys-function: Effect on rapid hemodialysis 1292

Collins T See Fries JWU et al 584Colmenares CJ See Muller GY et al 1055Colombo D (abst) 1439Colturi C (abst) 1445Colussi G (abst) 1441Conte G (abst) 1445Conz P See Ronco C et at 1383Cooper ME, Rumble iR, Allen Ti, O'Brien RC,

Jerums G, Doyle AE: Antihypertensive therapy in amodel combining spontaneous hypertension withdiabetes 898

Cooper ME See Jerums G et at 904Copley iB See Koenig KG et at 161Correa-Rotter R, Hostetter TH, Manivel IC, Eddy AA,

Rosenberg ME: Intrarenal distribution of clusterinfollowing reduction of renal mass 938

Correa-Rotter R, Hostetter TH, Rosenberg ME: Reninand angiotensinogen gene expression in experimentaldiabetes metlitus 796

Cosio FG See Nahman NS Jr. et al 396Cosseddu D (abst) 1445

Coupes B See Brenchley PE et al 933Couser WG (abst) 701Couser WG See Floege J et al 297Coutard M See Anidjar S et al 37:S-61Couttenye MM (abst) 1433Creech EA See Smith SR et al 199Crepaldi G See Fioretto P et a! 813Crepaldi G See Trevisan R et at 855Cristinelli L (abst) 1440, 1440Crowley S See Gupta S et at 1161

Cumming AD (abst) 699Cura A (abst) 1467, 1468Curatola A (abst) 1442, 1443Cushner HM See Koenig KG et at 161Cuzic S (abst) 480, 701Cuzzota F (abst) 1442, 1443Czekalski S (abst) 480Daerr WH (abst) 480D'Agostino A (abst) 1442D'Agostino A See Menè P et al 554Daha MR (abst) 695, 1431, 1435Dahl E (abst) 509Dahi K (abst) 507Dahl-JØrgensen K, BjØro T, Kierulf P, Sandvik L,

Bangstad Hi, Hanssen KF: Long-term glycemic con-trol and kidney function in insulin-dependent diabetesmellitus 920

Dahl-JØrgensen K (abst) 703Dahiquist G See Rudberg S et al 822Dakshinamurty KY (abst) 482Dalmak S (abst) 1466, 1466Dalva I (abst) 1468, 1470Dalva K (abst) 1468, 1470D'Amico G (abst) 697, 1445, 1446, 1447, 1447Dämmrich I (abst) 482Damsgaard EM, FrØland A, iØrgensen OD, Mogensen

CE: Eight to nine year mortality in known non-insu-lin dependent diabetics and controls 731

Daniel TO, Kumjian DA: Platelet-derived growth factorreceptors and phospholipase C activation 575

Danielson BG (abst) 500, 501, 501, 504, 504,506, 507, 509, 512

Daret D See Ramboer I et al 37:S-67Datta SK See Vlahakos DV et al 1690Daugaard H (abst) 501, 501, 502, 512Daugirdas JT See Nutting CW et al 166Daul A (abst) 488David C (abst) 480Davidson CJ See Collins DM et at 1292Davies iE See Ng LL et a! 872Davies M (abst) 699Davies M, Martin J, Thomas GI, Lovett DH: Protein-

ases and glomerular matrix turnover 671Davies RW (abst) 1438de Boland A (abst) 479De Broe ME (abst) 1433, 1435de Crombrugghe B (abst) 706De Ferrari ME (abst) 1441de Heer E (abst) 1430de Heer E See Bruijn JA et a! 5de Jong PE (abst) 1436de Leeuw PW (abst) 1436De Paoli Vitali E (abst) 1443Dc Pont JJHHM See Elving LD et al 862De Rango E (abst) 1445De Ridder L (abst) 1432


de Rooy-Roggekamp MC (abst) 1433de Vries PMJM See Kouw PM et al 440de Wolff FA (abst) 1432de Zeeuw D (abst) 1436de Zeeuw D, Janssen WMI, Jong PE: Atrial natriuretic

factor: Its (patho)physiological significance in humans(Editorial Review) 1115

Dean JD See Vora JP et al 829Decaux G See Soupart A et a! 1662Deckert T See Borch-Johnsen K et a! 719Deferrari G (abst) 1446Degli Esposti E (abst) 1442, 1442Deja A (abst) 488DelBo A (abst) 1446Delmez JA, Windus DW: Hemodialysis prescription

and delivery in a metropolitan community 1023Demirel F (abst) 1473den Ottolander GJFI (abst) 1433Dengler HJ (abst) 480Dengler TJ (abst) 480Denneberg T (abst) 502, 510, 510Denton DA See Tarjan E et al 37:S-97DePierre JW (abst) 507Deppisch R (abst) 486Derkx FHM (abst) 1437Dermietzel R See Minuth WW et al 215Dern K (abst) 479Desmoulière A, Gabbiani G: The cytoskeleton of arte-

rial smooth muscle cells during human and experi-mental artheromatosis 37:S-87

D'Haese PC (abst) 1433D'Haese PC See Vasilakakis DM Ct al 1400Di Dio F (abst) 1443Di Filippo S (abst) 1444Di Gennaro C (abst) 1445Di Rienzo M See Parati G et al 37:S-24DiBona GF, Epstein M, Mann JS, Nordlander M:

Introduction 36:S- 1Diet! P (abst) 488Dietz JR See Ramirez G et al 334Digenis PN See Vasilakakis DM et a! 1400Diggs RL See Choyke PL et at 1595Dijkstra C (abst) 1430Dilek K (abst) 1466, 1468Dinarello CA: Cytokines: Agents provacateurs in

hemodialysis9 683Distler A (abst) 484, 484, 485, 696Dixit VM: Thrombospondin and tumor necrosis

factor 679Djurup R (abst) 486Dodds R See Jones SL et a! 1620Dogliani M (abst) 1447Dolben J See Vora JP et at 829Dolman KM (abst) 1431Don BR See A1-Uzri A et a! 1701Donadon V See Trevisan R et a! 855Donker AJM (abst) 1433Donker AJM See Kouw PM et al 440Donohoe JF: Scleroderma and the kidney (Nephrotogy

Forum) 462DOrge SE (abst) 481Dorhout Mees EJ (abst) 1430Doria A See Trevisan R et at 855Doucet A: Na-K-ATPase in the kidney tubule in rela-

tion to natriuresis 37:S-1 18Douglas FL See Smith SR et al 199

Douglass D See Neufeld TK et al 1222Douma CE (abst) 1437Dousa TP See Rassier ME et al 88Downie I See Gibson 1W et a! 211Downie TT See Gibson 1W et a! 211Doyle AE See Cooper ME et al 898Draaijer P (abst) 1433Draaijer P See Kooman JP et al 1041Dransfield I See Hogg N et al 613Drenckhahn D (abst) 696Duley IT See Gabow PA et al 1311Duman N (abst) 1469Dündar S (abst) 1470, 1471, 1472Dunn DL See Cheung AHS et al 924Dunn MJ See Simonson MS et al 542Duranay M (abst) 1469Duranteau J See Berdeaux A et al 37:S-29DUrer Z (abst) 1468Dürr J See Hensen J et a! 1333Duva! DP See Freyss-Beguin MM et a! 37:S-79Dworkin LD See Lax DS et a! 1527Dworkin LD See Weisstuch JM et a! 36:S-33Dwyer AJ See Choyke PL et al 1595Dyke AC See Angus JA et al 37:S-73Eason J See Moore KP et al 1543Eberlein-Gonska M (abst) 490, 700Ebert J See Takahashi K et a! 1245Ecder ST (abst) 1466, 1473Eckardt K-U (abst) 481Eddy A (abst) 701Eddy AA See Correa-Rotter R et al 938Edefonti A (abst) 1439Edgar B See Elmfeldt D et a! 36:S-54Edgington TS See Ardaillou R et a! 361Edouard A See Berdeaux A et al 37:S-29Edwards BS See Ciresi DL et a! 1599Egfjord M (abst) 501, 508, 512Egido J (abst) 695Egsmose C (abst) 501, 502Ehmer B (abst) 493Ehmke H (abst) 481, 490Ehsani N (abst) 696Eidemak I (abst) 505, 505, 505Eiskjer H See Pedersen EB et al 36:S-82Ejerbiad S (abst) 512Ekblom P (abst) 705Ekblom P See Sorokin L et a! 657Ekim M (abst) 1471Ekinci A (abst) 1467El Yandouzi EH See Vrtovsnik F et at 983Elbai A (abst) 1467Eldegez U (abst) 1467, 1471Elger M (abst) 481, 696Elghozi J-L, Chalmers JP: Introduction 37:S-1Elghozi J-L See Cloarec-Blanchard L et at 37:S-14Eli A (abst) 1439Elliott TG See Messent JWC et a! 836Elmfeldt D, Nordlander M, Edgar B: Renal effects of

felodipine—A review 36:S-54Elving LD, Wetzels JFM, De Pont JJHHM, Berden

JHM: Is increased erythrocyte sodium-lithium coun-tertransport a useful marker for diabeticnephropathy9 862

Emanuelsson B-M (abst) 510Emmendorffer A (abst) 698Endou H See Nosaka K et a! 73


Endresen L (abst) 507England B See May RC et a! 1535Engler E See Bachman S et al 24Engler-Blum G (abst) 482Ensari C (abst) 1471Epper R (abst) 1445Epstein M: Calcium antagonists and the kidney: Impli-

cations for renal protection 36:S-66Epstein M See DiBona GF et al 36:S-1Erbas B (abst) 1469Erbay B (abst) 1469Erbengi T (abst) 1473Erden M (abst) 1467Erduran E (abst) 1471Erek E (abst) 1466, 1466Eren Z (abst) 1467Eriksson A See Heldin C-H et a! 571Erley C (abst) 495Erley CM, Harrer U, Kramer BK, Risler T: Renal he-

modynamics and reduction of proteinuria by a Va-sodilating beta blocker versus an ACE inhibitor 1297

Ernest I (abst) 510Ernst W (abst) 479, 498ErolC(abst) 1469Erol 0 (abst) 1466Esnault VLM, Soleimani B, Keogan MT, Brownlee

AA, Jayne DRW, Lockwood CM: Association of 1gMwith IgG ANCA in patients presenting with pulmo-nary hemorrhage 1304

Espinosa U (abst) 695Eum SH (abst) 1451Ewert BH, Jennette JC, Falk RJ: Anti-myeloperoxidase

antibodies stimulate neutrophils to damage humanendothelial cells 375

Fabbri A (abst) 1442, 1442Fadda GZ See Chervu I et a! 1501Fagugli RM (abst) 1440Fahrenholz F (abst) 1430Fairbanks LD (abst) 695Falk RJ See Ewert BH et al 375Fan P-Y See Spurney RF et a! 973Fan WW See K!eppe! MM et al 1629Fanelli V (abst) 1447Fanti P (abst) 486Farhood A See Truong LD et al 1676Faronato PP See Fioretto P et a! 813Fauchald P (abst) 507Faugere MC (abst) 496Fawdry RM See Nankivell BJ et a! 450Fedeli L (abst) 1440Federlin K (abst) 479Fehrman I (abst) 505Feingold KR (abst) 1438Feith GW (abst) 1430Fellin G (abst) 697, 1446FellstrOm B (abst) 501, 512Fenton S See Pei Y et al 1374Feriani M See Ronco C et al 1383Fernández JM, Carbonell ME, Mazzuchi N, Petruccelli

D: Simultaneous analysis of morbidity and mortalityfactors in chronic hemodialysis patients 1029

Ferrari P (abst) 481Ferrari P See Blumberg A et a! 369Ferrari S (abst) 1446Ferrario F (abst) 1447, 1447Ferraro T See Tarjan E et al 37:S-97

Ferrero M (abst) 1447Ferrone S See Canton AD et al 951Fidler V (abst) 1431

Figliuzzi M (abst) 697Fi!ho JCD See Canepa A et al 1016Findon G See Miller TE et al 1356Fioretto P, Muollo B, Faronato PP, Opocher G,

Trevisan R, Tiengo A, Mantero F, Remuzzi G, Crep-aldi G, Nosadini R: Relationships among natriuresis,atrial natriuretic peptide and insulin in insulin-depen-dent diabetes 813

Fioretto P See Trevisan R et al 855Fischer DB, Christman JW, Badr KF: Fifteen-S-hy-

droxyeicosatetraenoic acid (1 5-S-HETE) antangonizesthe chemotactic action and glomerular synthesis ofleukotriene B4 in the rat 1155

Fischer J (abst) 484, 484Fischer P (abst) 492FitzGerald GA See Remuzzi G et a! 1483Flanigan Mi See Symreng T et al 1064Flatmark A (abst) 509Flavier J-L See Kerr PG et a! 1035Fleming S (abst) 699, 701Fleuren GJ See Bruijn JA et al 5Floege J (abst) 701Floege J, Burns MW, Alpers CE, Yoshimura A, Pritzl

P, Gordon K, Seifert RA, Bowen-Pope DF, CouserWG, Johnson Ri: Glomerular cell proliferation andPDGF expression precede glomerulosclerosis in theremnant kidney model 297

Floege J See Johnson R et al 590Flyvbjerg A, Marshall SM, Frystyk J, Hansen KW,

Harris AG, Ørskov H: Octreotide administration indiabetic rats: Effects on renal hypertrophy and uri-nary albumin excretion 805

Foged N (abst) 510Fogo A See Yoshioka T et a! 1008Foidart JM (abst) 700Folkow B See Lever AF et al 37:S-51Ford DM, Briscoe DM, Shanley PF, Lum GM: Child-

hood membranoproliferative g!omerulonephritis typeI: Limited steroid therapy 1606

Fornasieri A (abst) 697Forneris G (abst) 1442Forsberg A-M See Canepa A et a! 1016Forsiund T (abst) 505Foster MH (abst) 695Foster MH See Vlahakos DV et at 1690Fou!ks Ci See Levy FL et a! 961Fouqueray B See Baud L et al 600Franco V (abst) 1441Frandsen H (abst) 505Frank J (abst) 482Frank JA See Choyke PL et al 1595Fransen R (abst) 1430Franz HE (abst) 483, 486, 492, 494, 495, 495Frattola A See Parati G et a! 37:S-24Fredin DM See Takeda M et a! 1713Frei U (abst) 481, 486, 487Frenken LAM, Wetzels JFM, Sluiter HE, Koene RAP:

Evidence for renal vasodilation in pre-dialysispatients during correction of anemia byerythropoietin 384

Frey BM See Schaad HJ et a! 420Frey Fi See Schaad Hi et al 420


Freyss-Beguin MM, Brussel EMM-V, Simon JM, DuvalDP: Regulation of membrane phospholipid metabo-lism in heart cell culture 37:S-79

Friedberg M (abst) 505, 505, 505Friedlander G See Vrtovsnik F et a! 983Friedman R See Lopes de Faria JB et a! 877Friedrich F (abst) 488Fries JWU, Collins T: Platelet-derived growth factor

expression in a transgenic model 584Frisenette-Fich C (abst) 504, 506Frisina N (abst) 1444Fritsch G (abst) 479FrØland A See Damsgaard EM et al 731Frolich JC See Radermacher J et al 1549Frost L (abst) 510Frystyk J See Flyvbjerg A et a! 805Fuiano G See Canton AD et al 951Fulpius T See Lemoine R et al 65Funder JW: Enzymes and the regulation of sodium

balance 37:S-114FunfstUck R (abst) 482Furthmayr H, Lankes W, Amieva M: Moesin, a new

cytoskeletal protein and constituent of filopodia: Itsrole in cellular functions 665

Fusaroli M (abst) 1442, 1442Fushimi K See Sakamoto H et al 350Fyhrquist F (abst) 505Gabbiani G: The biology of myofibroblasts 530Gabbiani G See Desmoulière A et a! 37:S-87Gabow PA, Johnson AM, Kaehny WD, Kimberling WJ,

Lezotte DC, Duley IT, Jones RH: Factors affectingthe progression of renal disease in autosomal-domi-nant polycystic kidney disease 1311

Gafter U, Kalechman Y, Sredni B: Induction of a sub-population of suppressor cells by a single bloodtransfusion 143

Gahi GM (abst) 486Galette A (abst) 486Gall M-A See Parving H-H et al 758Gallatin M (abst) 706Galli F (abst) 1443Gallieni M (abst) 1443Gambertoglio JG See A!-Uzri A et al 1701Ganadu M (abst) 1447Gandini E (abst) 1445, 1447, 1447GaBner B (abst) 497Ganten D (abst) 478, 496, 496Ganten D See Bachman S et a! 24Gariboglu S (abst) 1468Garibotto G (abst) 1446Garlick PJ See Bailmer PE et a! 132Gaskin G See Spencer SJW et a! 1059Gaspari F, Mosconi L, ViganO G, Perico N, Torre L,

Virotta G, Bertocchi C, Remuzzi G, Ruggenenti P:Measurement of GFR with a single intravenousinjection of nonradioactive iotha!amate(Technical Note) 1081

Gattone VH II See Harding MA et al 317Gavin JB See Miller TE et a! 1356Gawaz MP (abst) 482Geatti 0 (abst) 1443Geberth S (abst) 498Gedik Y (abst) 1471Geiger H (abst) 482Geissinger B See Olbricht CJ et al 966Gentile MG (abst) 1446

Gerbitz KD (abst) 705Gherardi G (abst) 1445Ghio L (abst) 1439Giacchino F (abst) 1439Giani M (abst) 1439Gibbons N See Singhal PC et al 1560Gibelli A (abst) 697Gibson 1W, Downie I, Downie TT, Han SW, More

JAR, Lindop GBM: The parietal podocyte: A studyof the vascular pole of the human glomerulus (Tech-nical Note) 211

Giefielmann S (abst) 491Gila JA (abst) 698Gilbert P (abst) 489Gilli P (abst) 1441, 1443Gil!ingham KJ See Cheung AHS et al 924Gillum D See Truong LD et at 1676Giordano A (abst) 1447, 1447Giordano F (abst) 1443Girard A See Cloarec-Blanchard L et al 37:S-14Girchev R (abst) 481Girton ME See Choyke PL et al 1595Giucastro G (abst) 1445Giudicelli J-F See Berdeaux A et al 37:S-29Giura C (abst) 1443Gladziwa U (abst) 482, 483, 493, 1434Gladziwa U See Kooman JP et al 1041Glassock RJ (abst) 700, 705Glas sock RJ See Ihm C-G et al 768Goch J (abst) 507Gogelein H (abst) 485Gogu S (abst) 1470Gôkce c (abst) 1469Gokce 0 (abst) 1469Goldberg H (abst) 706Goldfarb S See Rocco MV et at 107Goldschmeding R (abst) 1431Goldsmith DJA, Hilton PJ: Relationship between

intracellular proton buffering capacity andintracellular pH 43

Gonenc F (abst) 1468, 1470Gonick HC See Khalil-Manesh F et al 1192Goodman S See von der Mark K et a! 632Goodman SL: a6/3l integrin and laminin E8: An in-

creasingly complex simple story 650Gordon K See Floege J et al 297Gosselink MAHE (abst) 1437Gotze M (abst) 478Gould YE See Korhonen M et al 641Gove C See Moore KP et al 1543Gown AM See Alpers CE et al 1134Grabensee B (abst) 485, 487Grabowski P (abst) 699Grant M See Neufeld TK et al 1222Grantham JJ See Harding MA et a! 317Grantham JJ See Neufeld TK et al 1222Grassi C (abst) 1443Grayburn PA See Levy FL et a! 961Graziani G (abst) 1446Greca GL See Ronco C et a! 1383Green DF, Hwang KH, Ryan US, Bourgoignie JJ: Cu!-

ture of endothelial cells from baboon and humanglomeruli 1506

Green DF, Resnick L, Bourgoignie JJ: HIV infects gb-merular endothelial and mesangia! but not epithelialcells in vitro 956


Greenwood C See Pei Y et al 1374Greven J (abst) 478, 479Grond J (abst) 702, 1431, 1432Grond J See Wolthuis A et a! 124Gronhagen-Riska C (abst) 499, 503, 508Grootendorst AF (abst) 1434Gross P(abst) 485Grosser S (abst) 480Grover PK, Ryall RL, Marshall VR: Calcium oxalate

crystallization in urine: Role of urate andglycosaminoglycans 149

Groves BM See Hensen J et al 1333Gruber E See Ittel TH et a! 1340Grune T (abst) 494Grunewald JM (abst) 483Grunewald RW (abst) 483, 492GrUnfeld i-P See Cloarec-Blanchard L et al 37:S-14Grunicke H (abst) 488Grupe WE (abst) 1456Grupp C (abst) 494Grupp CT (abst) 483GrUtzmacher P (abst) 496Grzeszczak W (abst) 488Guarena C (abst) 1442, 1442Gudat F (abst) 1445Guerra L (abst) 1439Guignard J-P See Pedrotti A et al 80Guillermo R (abst) 700Guillermo R See Ihm C-G et a! 768Gulbins E (abst) 492GüilU M (abst) 1468Gülliilü M (abst) 1466Gultepe M (abst) 1468GOne Z (abst) 1470Gupta S, Rifici V, Crowley S, Brownlee M, Shan Z,

Schiondorif D: Interactions of LDL and modifiedLDL with mesangial cells and matrix 1161

Gurland Hi (abst) 482Gusmano R See Canepa A et al 1016Gutjahr E See Olbricht Ci et a! 966Gyotoku Y See Lemoine R et al 65Ha C-Y (abst) 1448Ha SK (abst) 1448, 1456, 1462Haas C (abst) 483Haberstroh U (abst) 483, 495, 696Hack CE (abst) 1431, 1438Hackeng WHL (abst) 1433Hackenthal E See Sakai T et a! 533Hacki A (abst) 484Hah JO (abst) 1465Haist K (abst) 495Haites NE (abst) 699, 703, 706Hakim R See Himmelfarb J et al 388Halbhuber K-i (abst) 482Halgunset i (abst) 500Hailer H (abst) 484, 484, 696Hallmann R (abst) 696Halse J (abst) 509Hamamizade NM (abst) 1472Hamm LL See Bonilla-Felix M et a! 1150Hammer M (abst) 508, 508Hammond WS See Almeida ARP et at 1494Hampl H (abst) 494Hamzeh Y See Said R et al 414Han DC(abst) 1455, 1458, 1459, 1459Han DS (abst) 1448, 1456, 1458, 1459, 1462, 1463, 1463

Han HS (abst) 1461Han iS (abst) 1453, 1454Han SW See Gibson 1W et a! 211Hanatani M (abst) 484Handt S See Ittel TH et al 1340Hanna JD See Santos F et al 356Hannemann J (abst) 484Hänsch GM (abst) 486, 496Hansen FM (abst) 508Hansen HE (abst) 502, 508, 510Hansen KW, Christensen CK, Anderson PH, Pederson

MM, Christiansen iS, Mogensen CE: Ambulatoryblood pressure in microalbuminuric type 1 diabeticpatients 847

Hansen KW See Flyvbjerg A et a! 805Hansen KW See Pederson MM et a! 883Hansen SI See Hoim J et al 50Hansen-Schmidt S (abst) 492Hanssen KF (abst) 703Hanssen KF See Dahl-JØrgensen K et at 920Hara M See Ohashi K et al 1646Haraldsson BS, iohnsson EKA, Rippe B: Glomerular

permselectivity is dependent on adequate serum con-centrations of orosomucoid 310

Harding MA, Gattone VH II, Grantham ii, Calvet JP:Localization of overexposed c-myc mRNA in poly-cystic kidneys of the cpk mouse 317

Hardlund i (abst) 501Harendza S (abst) 491Harlow JE See Tilton RG et al 778Harman N (abst) 1472Harrer U See Erley CM et a! 1297Harris AG See Flyvbjerg A et a! 805Harris DCH See Nankivell Bi et a! 450Hartman A (abst) 703Hasanoglu E (abst) 1472, 1473Haslett C (abst) 704Hasslacher C (abst) 484Haugen OA (abst) 500Hauser IA (abst) 702Haussinger D (abst) 496Haverty TP See Alvarez Ri et al 14Havu N See Nordlander M et a! 36:S-100Hawk CT See Schafer JA et al 255Hayashi H, Karasawa R, Inn H, Saitou T, Ueno M,

Nishi S, Suzuki Y, Ogino 5, Maruyama Y, Kouda Y,Arakawa M: An electron microscopic study of gb-meruli in Japanese patients with non-insulin depen-dent diabetes mellitus 749

Hayes C See Yanagisawa H et a! 1000Hayry P See Isoniemi HM et ai 155Haznedar R (abst) 1472Hdersdal C (abst) 505, 506He Ci, Kanfer A: Quantification and modulation of

thrombomodulin activity in isolated rat and humanglomeruli 1170

Head GA: Central monoamine neurons and cardiovas-cular control 37:S-8

Hebert CL See Nahman NS Jr. et al 396Heeger P, Wolf G, Meyers C, Sun MJ, O'Farrell SC,

Krensky AM, Neilson EG: Isolation and characteri-zation of cDNA from renal tubular epithelium encod-ing murine Rantes 220

Hefferton D See Barrett Bi et a! 1274Heidenreich S (abst) 495Heidland A (abst) 482, 704


Heimburger 0, Waniewski J, Werynski A, Liodhoim B:A quantitative description of solute and fluid trans-port during peritoneal dialysis 1320

Heinrichs A See Ittel TH et al 1340Helaakoski T(abst) 706Heldin C-H, Ostman A, Eriksson A, Siegbahn A, Claes-

son-Welsh L, Westermark B: Platelet-derived growthfactor: Isoform-specific signaling via heterodimeric orhomodimeric receptor complexes 571

Hellings SE See Takeda M et al 1713Helmchen U (abst) 485, 497Hennerkes B See Minuth WW et al 215Henrich WL See Levy FL et a! 961Hensen J, Abraham WT, Lesneefsky EJ, Levenson B,

Groves BM, Schroder K, Schrier RW, DUrr J: Atrialnatriuretic peptide kinetic studies in patients with car-diac dysfunction 1333

Hercz G See Pei Y et al 1374Herlitz H (abst) 510Herlitz H: Long-term effects of felodipine in patients

with reduced renal function 36:S-110Hermle M (abst) 498Hermie M See Bock HA et a! 275Hernando L (abst) 695Herndon J See Bonilla-Felix M et a! 1150Herzog R (abst) 494Heublein DM See Ciresi DL et al 1599Hiatt WR, Koziol BJ, Shapiro TI, Brass EP: Carnitine

metabolism during exercise in patients on chronichemodialysis 1613

Hildebrandt F (abst) 485Hill GS See Quan Zy et al 326Hill RD See Messent JWC et at 836Hilton PT See Goldsmith DJA et a! 43Himmelfarb J, Zaoui P, Hakim R, Holbrook D: Modu-

lation of granulocyte LAM-i and MAC-i during dial-ysis—A prospective, randomized controlled trial 388

Ho YD (abst) 1456Hocher B (abst) 485Hoedemaeker PhJ (abst) 1430Hoedemaeker PT (abst) 700Hoedemaeker PT See Bruijn TA et al 5Hoefliger N See Vanholder R et al 1707Hoffstedt E (abst) 506Hofstädter F See Ittel TH et a! 1340Hogg N (abst) 704Hogg N, Bennett R, Cabanas C, Dransfield I: Leuko-

cyte integrin activation 613HØier-Madsen M See HoIm T et al 50Holbrook D See Himmelfarb J et a! 388Holdaas H (abst) 507Hollenbeck M (abst) 485Holliday MA See Al-Uzri A et al 1701HoIm J, Hansen SI, HØier-Madsen M, Bostad L: A

high-affinity folate binding protein in proximal tubulecells of human kidney 50

Hoistein-Rathlou NH (abst) 508HolthOfer H (abst) 696Homma T See Takeda M et a! 1713Hommel E See Borch-Johnsen K et al 719Honda K See Ohashi K est a! 1646Hong CD (abst) 1450, 1458Hong SP (abst) 1450Honkanen E (abst) 499, 503, 508Hoover RL See Takeda M et al 1713Hopfenmuller B (abst) 486

Hoppe A (abst) 492Hoppe D (abst) 496}-Iörkkö S, Savolainen MJ, Kervinen K, Kesäniemi YA:

Carbamylation-induced alterations in low-densitylipoprotein metabolism 1175

Horl WH (abst) 479Horvei G See Ofstad J et al 36:S-8Hostetter TH See Correa-Rotter R et al 796Hostetter TH See Correa-Rotter R et al 938Hostetter TH See Salahudeen AK et a! 183Houhou S See Cloarec-Blanchard L et a! 37:S-l4Houillier P, Borensztein P, Bichara M, Paillard M, Pri-

gent A: Chronic neutral phosphate supplementationinduces sustained, renal metabolic alkalosis 1182

Hoyer T (abst) 485Huang S (abst) 704Hudkins KL See Alpers CE et a! 1134Huh KB (abst) 1448Huitema S (abst) 1432Humphries MJ: Peptide recognition motifs involved in

the binding of integrins to their ligands 645Hupp T (abst) 498Huwiler A (abst) 490Huysmans FTM, van Hamersvelt HW, Sluiter HE,

Wetzels JFM, Koene RAP: Acute renal effects offelodipine in hypertensive patients with kidneydisease 36:S-106

Huysmans FTM See van Hamersvelt HW et al 36:S-73Hwang KH See Green DF et at 1506Hwang SD (abst) 1455, 1458, 1459, 1459Hwang Y (abst) 1449Hylander B (abst) 503, 504Hyver SW See Pallone TL et a! 1366Ido Y, Tilton RG, Chang K, Pugliese G, Williamson

JR: Rapid measurement of glomerular filtration ratein small animals (Technical Note) 435

Igarashi P (abst) 485Ihm CG (abst) .... 700, 702, 1449, 1449, 1452, 1454, 1456, 1462Ihm C-G, Lee GSL, Nast CC, Artishevsky A, Guil!-

ermo R, Levin PS, Glassock RJ, Adler SG: Earlyincreased renal procallogen ai(IV) mRNA levels instreptozotocin induced diabetes 768

lida H See Johnson R et a! 590Ilhan N (abst) 1469Imai H See Komatsuda A et al 1204Imbasciati E (abst) 1445Imholz ALT (abst) 1436Inagami T See Takeda M et al 1713Ingerslev T (abst) 502Inn H See Hayashi H et a! 749lozzo RV See Alvarez RJ et a! 14

Ipek Cingi M (abst) 1467Irzyniec T (abst) 485Iimer A (abst) 1470Islam S See Nutting CW et a! 166Isoniemi HM, Krogerus L, van Willebrand F, Taskinen

E, Ahonen J, Hayry P: Histopathological findings inwell-functioning, long-term renal allografts 155

Itoh H See Komatsuda A et al 1204Ittel TH, Gruber E, Heinrichs A, Handt S, Hofstädter

F, Sieberth H-G: Effect of fluoride on aluminum-in-duced bone disease in rats with renal failure 1340

Iversen BM See Ofstad J et a! 36:S-8Izui S See Lemoine R et a! 65Jacobsen BA (abst) 511


Jaffa AA, Chai KX, Chao J, Chao L, Mayfield RK: Ef-fects of diabetes and insulin on expression of kal-likrein and renin genes in the kidney 789

Jahn B (abst) 486, 496Jandhyala BS See Chintala MS et al 36:S-94Jang TJ (abst) 1463Janssen WMI See de Zeeuw D et a! 1115Jarrett RJ See Messent JWC et a! 836Jayne DRW See Esnault VLM et al 1304Jenkins DAS (abst) 699Jennette JC See Ewert BH et a! 375Jennings GL See Angus JA et a! 37:S-73Jensen C (abst) 503Jensen G (abst) 512Jensen JS See Borch-Johnsen K et a! 719Jensen LT (abst) 501, 502, 503Jeong HJ (abst) 1453Jeong MS (abst) 1448, 1451Jeppesen L (abst) 505, 506Jeppsson J-O (abst) 510Jerums G, Allen T, Tsa!amandris C, Cooper ME:

Angiotensin converting enzyme inhibition andcalcium channel blockade in incipient diabeticnephropathy 904

Jerums 6 See Cooper ME et a! 898Joffe P (abst) 503, 503, 503Jogestrand T (abst) 504Johansson A-C (abst) 504Johnsen SA (abst) 512Johnson AM See Gabow PA et al 1311Johnson R, lida H, Yoshimura A, Floege J, Bowen-

Pope DE: Platelet-derived growth factor: A poten-tially important cytokine in glomerular disease 590

Johnson RJ (abst) 701Johnson RJ See Alpers CE et al 1134Johnson RJ See Floege J et al 297Johnsson EKA See Haraldsson BS et a! 310Johnston CI See Luft FC et al 36:S-114Joles JA (abst) 1438Jones C(abst) 701Jones H (abst) 1438Jones JM See Simon son MS et a! 542Jones MC (abst) 703Jones RH See Gabow PA et a! 1311Jones SL, Kontessis P, Wiseman M, Dodds R, Bognetti

E, Pinto J, Viberti G: Protein intake and blood glu-cose as modulators of GFR in hyperfiltering diabeticpatients 1620

Jones SL See Walker JD et al 741JongPESeedeZeeuwDetal 1115JØrgensen AF (abst) 510JØrgensen F See Parving H-H et a! 758JØrgensen HE See Parving H-H et a! 758JØrgensen OD See Damsgaard EM et a! 731JOnes A (abst) 486JØrstad S (abst) 507Jover B See Mimran A et al 37:S- 107Julien C See Barrès C et al 37:S-19Jungmann E (abst) 486, 492Jutila MA (abst) 696Kaehny WD See Gabow PA et a! 1311Kagami S See Border WA et al 566Kâgedal B (abst) 510Kahi A (abst) 486Kala A-R (abst) 503Kalechman Y See Gafter U et al 143

Kallenberg CGM (abst) 1435Kamper AL (abst) 499, 508Kampf D (abst) 486Kämpf W (abst) 492Kanfer A See He CJ et al 1170Kang CM (abst) 1449, 1460, 1465KangFT(abst) 1455, 1455Kang KW (abst) 1449Kang SH (abst) 1453Kang S-K (abst) 1448Kang YJ (abst) 1451Kanwar YS See Watanabe Y et al 1262Kaplan R See Wilkes BM et a! 992Kapoor V See Arnolda L et al 37:S-2Karakullukçu F (abst) 1467Karaoglan U (abst) 1473Karasawa R See Hayashi H et al 749Karatan 0 (abst) 1469Karsenty G (abst) 706Kashgarian M, Sterze! RB: The pathobiology of the

mesangium 524Kashihara N See Watanabe Y et a! 1262Kashtan CE See Kleppel MM et a! 1629Katholi RE See Barfuss DW et al 1143Katinios A See Magoula I et a! 1349Kato T See Takahashi K et a! 1245Katz M See Viahakos DV et a! 1690Kavak!i K (abst) 1467Kawai R See Ohashi K et a! 1646Kawasaki K, Yaoita E, Yamamoto T, Kihara I: Deple-

tion of CD8 positive cells in nephrotoxic serum ne-phritis of WKY rats 1517

Kaygisiz Z (abst) 1467Kaysen GA (abst) 1438Keck I (abst) 489Keen H See Messent JWC et a! 836Keen H See Walker JD et al 741Keller F (abst) 485Kemmer FW (abst) 485, 487Kent G See Barrett BJ et al 1274Keogan MT See Esnault VLM et a! 1304Kerjaschki D: Molecular pathogenesis of membranous

nephropathy (Nephro!ogy Forum) 1090Kerr PG, Argues A, Flavier J-L, Canaud B, Mion CM:

Comparison of hemodialysis and hemodiafi!tration: Along-term longitudinal study 1035

Kervinen K See HOrkkO S et a! 1175Kesäniemi YA See HOrkkO S et a! 1175Kesteloot D (abst) 1432Khalil-Manesh F, Gonick HC, Cohen AH, Alinovi R,

Bergamaschi E, Mutti A, Rosen VJ: Experimentalmodel of lead nephropathy. I. Continuous high-doselead administration 1192

Khang KW (abst) 1460Kielstein R (abst) 488Kienle S (abst) 495, 495Kiersztejn M See Chervu I et a! 1501Kieruif P See Dahl-JØrgensen K et a! 920Kihara I See Kawasaki K et al 1517Kilburg M (abst) 491Kilicturgay S (abst) 1473Killen PD (abst) 706Kim BU (abst) 1464Kim CH (abst) 1455Kim CY (abst) 1462Kim FS (abst) 1455


Kim G-H (abst) 1454, 1455Kim HC (abst) 1453, 1456, 1458, 1460Kim HJ (abst) 1450, 1450, 1451, 1457, 1463Kim HK (abst) 1452, 1455, 1459Kim HS (abst) 1448, 1456, 1459, 1463, 1463Kim JC (abst) 1457Kim JS (abst) 1449Kim JW (abst) 1456Kim KR (abst) 1451Kim KS (abst) 1456Kim KY (abst) 1463Kim MC (abst) 1461Kim MJ (abst) 1449, 1449, 1452, 1453, 1454, 1456,

1462, 1462Kim MK (abst) 1457Kim MS (abst) 1457Kim P (abst) 1453Kim S (abst) 1453, 1454, 1460Kim SB (abst) 1450, 1458Kim SH (abst) 1457, 1462Kim SY (abst) 1448, 1455, 1457, 1464, 1464Kim WI (abst) 1464Kim WJ (abst) 1450Kim WM (abst) 1457Kim Y (abst) 704, 1454Kim YG (abst) 1453, 1461Kim Yl (abst) 1453, 1460Kim YK (abst) 1448, 1448, 1456, 1458, 1459,

1462, 1463, 1463

Kim YS (abst) 1448, 1455, 1455, 1457, 1460,

1460, 1464, 1464, 1465

Kimberling WJ See Gabow PA et a! 1311King GL See Nayak RC et a! 1638Kinne R (abst) 1444Kinne RKH (abst) 483Kirazli S (abst) 1471, 1472Kirchheim HR (abst) 481, 490Kirste T (abst) 698Klahr S See Reyes AA et a! 100Klahr S See Reyes AA et at 403Klahr S See Yanagisawa H et al 1000Kianke B See Radermacher J et al 1549Klar N (abst) 1435Klein J (abst) 486Kleinknecht D See Ma! F et a! 445Kieppel M (abst) 704Kleppel MM, Fan WW, Cheong HI, Kashtan CE,

Michael AF: Immunochemical studies of the Alportantigen 1629

Kliem V (abst) 486, 487K!inger M (abst) 482, 487Kioth S See Minuth WW et al 215Kiotman PE See Smith SR et at 199Klotz U (abst) 482Knoers VVAM (abst) 1430Knudsen F (abst) 502Knudsen L (abst) 502Ko CW (abst) 1450Ko KW (abst) 1453, 1454, 1461

Kocak H (abst) 1468

Kocak N (abst) 1466, 1467, 1473Koch KM (abst) 481Koch KM: Dialysis-related amyloidosis (Nephrology

Forum) 1416Koch M (abst) 487, 701Koene RAP (abst) 1430

Koene RAP See Frenken LAM et al 384Koene RAP See Huysmans FTM et al 36:S-106Koene RAP See van Hamersvelt 11W et al 36:S-73Koenig KG, Lindberg JS, Zerwekh JE, Padalino PK,

Cushner HM, Copley JB: Free and total 1,25-dihydroxyvitamin D levels in subjects with renaldisease 161

Koeser T (abst) 487Kofoed-Enevoidsen A: Inhibition of glomerular glucosa-

minyl N-deacetylase in diabetic rats 763Kogan BA See Al-Uzri A et at 1701Koh YB (abst) 1460, 1464, 1464Köhler H (abst) 487Kokot F (abst) 488KOIIer M (abst) 496, 496Kolmannskog F (abst) 500Komatsuda A, Wakui H, Imai H, Nakamoto Y, Miura

AB, Itoh H, Tashima Y: Rena! localization of theconstitutive 73-kDa heat-shock protein in normal andPAN rats 1204

Kon V See Takeda M et al 1713Konieczkowski M See Sedor JR et al 595Kontessis P See Jones SL et al 1620Koo JH (abst) 1450Koo WS (abst) 1448, 1455, 1457, 1464, 1464, 1465

Kool M (abst) 1433Kooman JP (abst) 1434, 1435Kooman JP, Wijnen JAG, Draaijer P, van Bortel

LMAB, Gladziwa U, Peltenburg HG, Struyker-Boud-ier HAJ, van Hooff JP, Leunissen KML: Complianceand reactivity of the peripheral venous system inchronic intermittent hemodialysis 1041

Koomans HA (abst) 1430, 1434, 1435, 1436Koomen GCM (abst) 1436, 1437, 1437Koomen GCM See Struijk DG et a! 1668Koopman MG (abst) 1437, 1437Kope W (abst) 487Kopp JB, Bianco P, Young MF, Termine JD, Robey

PG: Renal tubular epithelial cells express osteonectinin vivo and in vitro 56

Koray Z (abst) 1469Korhonen M, Laitinen L, Ylänne J, Gould YE, Virta-

nen I: Integrins in developing, normal and malignanthuman kidney 641

Korner PT, Bobik A, Angus JA: Are cardiac and vascu-lar "amplifiers" both necessary for the developmentof hypertension9 37:S-38

Korner P1 See Angus JA et at 37:S-73Koruk M (abst) 1472Koster HPG (abst) 1434Köster W (abst) 479Kouda Y See Hayashi H et a! 749Kouw PM, Olthof CG, ter Wee PM, Oe LP, Donker

AJM, Schneider H, de Yries PMJM: Assessment ofpost-dialysis dry weight: An application of the con-ductivity measurement method (Technical Note) 440

Koziol BJ See Hiatt WR et a! 1613Kozma V (abst) 511Kragballe K (abst) 508Kramarz S (abst) 487Kramer BK See Erley CM et a! 1297Kramer HJ, Meyer-Lehnert H, Mohaupt M: Role of

calcium in the progression of renal disease: Experi-mental evidence 36:S-2

Krause R (abst) 488Krediet RT (abst) 1433, 1436, 1437


Krediet RT See Struijk DG et a! 1668Kreisberg JI (abst) 700Krensky AM See Heeger P et a! 220Krieg RJ See Santos F et a! 356Kristensen JK (abst) 509Kriz W (abst) 478, 481, 489, 696Kriz W See Sakai T et al 533Krogerus L See Isoniemi HM et a! 155Krogsgaard K (abst) 502Krol MC (abst) 695Krolewski AS See Barzilay J et a! 723Krzymañski M (abst) 488Kuch R (abst) 488Kuchta G (abst) 492KUhn B (abst) 482KUhn R (abst) 482Kuhn W (abst) 489Kumjian DA See Daniel TO et a! 575Kunkel SL (abst) 695Kunkel SL See Schmouder RL et al 191Kunzendorf U See Neumayer H-H et a! 36:S-87Kurkus J (abst) 509Kurnik BRC See Weisberg LS et a! 1408Kurnik PB See Weisberg LS et al 1408Kurtz A (abst) 481, 493Küster S (abst) 488KUtUkçUIer N (abst) 1467KUtUkç!üler N (abst) 1468Kvam Fl See Ofstad J et al 36:S-8Kwak KC (abst) 1455, 1455Kwon HM (abst) 1459Kwon HS (abst) 1451Kwon TH (abst) 1457, 1462Kwon YJ (abst) 1452, 1455, 1459La Milia V (abst) 1444Laborde K See Shahedi M et a! 455Lacape G See Ramboer I et al 37:S-67Ladefoged S (abst) 505, 508Ladefoged SD (abst) 502, 503, 505, 508Laffel LMB See Barzilay J et a! 723Lafferty HM See Anderson S et a! 891Laitinen L See Korhonen M et a! 641Lajeunesse D See Brunette MG et a! 281Lajeunesse D See Brunette MG et al 289Lamaziere J-MD See Ramboer I et al 37:S-67Lambers A (abst) 1430Lambert MB See Collins DM et al 1292Lamberts LV (abst) 1433Lamberts LV See Vasilakakis DM et al 1400Lameire N (abst) 1432

Lamperi D (abst) 1443Lane PH, Steffes MW, Mauer SM: Estimation of gb-

merular volume: A comparison of four methods(Technical Note) 1085

Lang F (abst) 488, 496Langhans S (abst) 483Lankes W See Furthmayr H et al 665Larochelle P: Renal tubular effects of calcium

antagonists 36:S-49Larrue J See Ramboer I et al 37:S-67Larsen S See Parving H-H et al 758Larsson K (abst) 507Laske V (abst) 478Lassen A (abst) 502Lauchert W (abst) 489Laurent G See Charra B et a! 1286

Lausten GS (abst) 508Lavarda F (abst) 1445Law N (abst) 697Lax DS, Benstein JA, Tolbert E, Dworkin LD: Effects

of salt restriction on renal growth and glomerular in-jury in rats with remnant kidneys 1527

Le Grimellec C See Vrtovsnik F et al 983Leclercq C See Beuve CS et a! 37:S-45LeDuc J (abst) 1431Lee BJ (abst) 1455Lee C-E (abst) 1453Lee DK (abst) 1458Lee GSL (abst) 700Lee GSL See Ihm C-G et al 768Lee HB (abst) 1455, 1458, 1459, 1459Lee HC (abst) 1448Lee HS (abst) 1453, 1460Lee HW (abst) 1431Lee HY(abst) 1448, 1451, 1456, 1458, 1459,

1462, 1463, 1463Lee IH (abst) 1465Lee J (abst) 1451Lee JD (abst) 1464Lee JJ (abst) 1449Lee JK (abst) 1453Lee JS (abst) 1453, 1453, 1454, 1460Lee JT (abst) 1462Lee JY (abst) 1451, 1451Lee KB (abst) 1462Lee KK(abst) 1463Lee KU (abst) 1450Lee KY (abst) 1460Lee MA (abst) 478Lee MH (abst) 1450Lee SG (abst) 1458Lee SH (abst) 1461Lee SK (abst) 1452, 1458, 1459, 1459Lee SR(abst) 1457, 1461, 1461Lee SY (abst) 1452Lee TW (abst) 1449, 1449, 1452, 1454, 1456, 1462Lee YC (abst) 1450, 1452

Lee YS (abst) 1458Lefkowith J See Reyes AA et a! 100Lehmann H (abst) 503Lelongt B See Shahedi M et a! 455Lemkes HHPJ (abst) 1432Lemley KV See Sakai T et al 533Lemoine R, Berney T, Shibata T, Fulpius T, Gyotoku

Y, Shimada H, Sawada 5, Izui 5: Induction of "wire-loop" lesions by murine monoclonal IgG3cryoglobulins 65

Lemoniatou E (abst) 1433Lemoniatou E See Vasilakakis DM et al 1400

Lempinen M (abst) 490Leonardis D (abst) 1443Leonhart KL See Nahman NS Jr. et a! 396Lesneefsky EJ See Hensen J et al 1333Leunissen KML (abst) 1433, 1434, 1435Leunissen KML See Kooman JP et a! 1041Levenson B See Hensen J et al 1333

Lever AF, Lyall F, Morton JJ, Folkow B: AngiotensinII, vascular structure and blood pressure 37:S-5 1

Levin PS See Ihm C-G et a! 768Levy FL, Grayburn PA, Foulks CJ, Brickner ME,

Henrich WL: Improved left ventricular contractilitywith cool temperature hemodialysis 961

1762 Author Index. Vol. 41

Leyssac PP (abst) 499, 508Lezotte DC See Gabow PA et al 1311Libetta C (abst) 1445Lillevold PE (abst) 500Urn CS (abst) 1460Lirn HE (abst) 1462Urn IS (abst) 1452Lim TH (abst) 1458Urn VS See Syrnreng T et a! 1064Lin J-T See Rassier ME et al 88Linari F (abst) 1445Lindberg iS See Koenig KG et al 161Lindberger K (abst) 506Linde T (abst) 506, 509Lindell A (abst) 510Lindergârd B (abst) 509Lindgren S (abst) 510Lindh E (abst) 507Lindholm A (abst) 505Lindholrn B See Heimburger 0 et a! 1320Lindner G (abst) 1441Lindop GBM See Gibson 1W eta! 211Lindqvist B (abst) 511Lindschau C (abst) 484, 696Lindsjö M (abst) 512Lindström H (abst) 507Linné T (abst) 499Lins L-E (abst) 504Liu E (abst) 701Ljunghall S (abst) 507L1ewe11yn-Smith I See Arnolda L et al 37:S-2Lloyd MA See Ciresi DL et al 1599Locatelli F (abst) 1444Lockwood CM See Esnault VLM et a! 1304Lodde P (abst) 1447Logue B See May RC et a! 1535LØkkegaard H (abst) 505, 513LØkkegaard H See Parving H-H et a! 758LØkkegaard N (abst) 502Lonnemann G (abst) 481Lopes de Faria JB, Friedrnan R, Tariq T, Viberti GC:

Prevalence of raised sodium-lithiurn conntertransportactivity in type I diabetic patients 877

LOpez-Farre A (abst) 695Lorbeer B (abst) 483Lovett DH See Davies M et a! 671Lubrich-Birkner I (abst) 489Luff SE See McLachlan EM et a! 37:S-56Luft FC, Johnston CI: Are calcium antagonists of

value in ameliorating the course of chronic renaldisease9 36:S-l14

Lurn GM See Ford DM et al 1606Lundberg L (abst) 511Lundberg M (abst) 502Lupi A See Ronco C et al 1383Lusenti T (abst) 1441Lusiani L See Trevjsan R et al 855Lyall F See Lever AF et al 37:S-51Machado IV See Muller GY et al 1055Macica CM See Wilkes BM et al 992Mackensen-Haen S (abst) 484Macnicol AR See Watson ML et al 206Madaio MP (abst) 695Madaio MP See Viahakos DV et al 1690Madri JA (abst) 702, 705

Madri JA, Marx M: Matrix composition, organizationand soluble factors: Modulators of microvascular celldifferentiation in vitro 560

Madri JA, Sterzel RB: Introduction 523Magil AB See Wakai S et al 428Magnusson M (abst) 504Magoula I, Tsapas G, Mavromatidis K, Katinios A:

Single kidney function: Early and late changes inurate transport after nephrectomy 1349

Mailloux J See Brunette MG et al 281Mailloux J See Brunette MG et a! 289Majorca R (abst) 1440, 1440Mak RHK: Intravenous 1,25 dihydroxycholecalci-

ferol corrects glucose intolerance in hemodialysispatients 1049

Makjno H See Watanabe Y et al 1262Ma! F, Meyrjer A, Callard P, Kleinknecht D, Altmann

i-i, Beaugrand M: The diagnostic yield of transjugu-lar renal biopsy. Experience in 200 cases (TechnicalNote) 445

Malfi B (abst) 1439Mall G (abst) 485Mallamaci F (abst) 1443, 1444Mallick NP See Brenchley PE et a! 933Malluche HH (abst) 486, 496Maly K (abst) 488Md!yusz M (abst) 484Mályusz T (abst) 484Mancia G See Parati G et al 37:S-24Mancini E (abst) 1446Manivel JC See Correa-Rotter R et a! 938Mann H (abst) 482, 483Mann iS See DiBona GF et a! 36:S-1Manna G (abst) 1446Mans jer P See Beuve CS et a! 37:S-45Manson Wi (abst) 1435Mansour J See Berl T et a! 37Mantero F See Fioretto P et al 813Manuel A See Pei Y et a! 1374Manzione A (abst) 1439Marabini M (abst) 1446Marangella M (abst) 1445Marcussen N (abst) 499Markovic-Lipkovski J (abst) 489, 489Marshall SM See Flyvbjerg A et al 805Marshall VR See Grover PK et a! 149Martin D See Reyes AA et a! 403Martin J See Davies M et a! 671Martin LL See Smith SR et a! 199Martinelli D (abst) 1443Marurno F See Sakamoto H et a! 350Maruyama Y See Hayashi H et a! 749Marx M See Madri JA et a! 560Mascher G (abst) 506Maser E (abst) 479Mason PJ (abst) 704Massara C (abst) 1439Massry SG See Chervu I et a! 1501Masud T See May RC et a! 1535Matas AJ See Cheung AHS et a! 924Mathjesen ER See Borch-Johnsen K et a! 719Mauer M, Mogensen CE, Viberti GC: Introduction 717Mauer SM, Sutherland DER, Steffes MW: Relationship

of systemic blood pressure to nephropathology in in-sulin-dependent diabetes mellitus 736

Mauer SM See Lane PH et a! 1085


Mauer SM See Vernier RL et a! 1070Mavromatidis K See Magoula I et a! 1349May RC, Masud T, Logue B, Bailey J, England B:

Chronic metabolic acidosis accelerates whole bodyproteolysis and leucine oxidation in awake rats 1535

Mayfield RK See Jaffa AA et al 789Mazzucco G (abst) 1447Mazzuchi N See Fernández JM et a! 1029McCann WP See Barfuss DW et al 1143McCulloch L (abst) 701McCune BK See Roberts AB et al 557McDonald J See Barrett BJ et al 1274McFarland H See Choyke PL et a! 1595McHugh LE See Cheung AHS et al 924McIntyre Si See Rassier ME et al 88McKay N (abst) 706McKay NG (abst) 703McKinley Mi: Common aspects of the cerebral regula-

tion of thirst and renal sodium excretion 37:S-102McLachlan EM, Luff SE: Sympathetic innervation of

renal and extra-renal arterial vessels 37:S-56McLeod AM (abst) 699McManamon PJ See Barrett BJ et al 1274McNurlan MA See Ballmer PE et a! 132Medina J (abst) 698Mehisen J (abst) 505, 506MenèP(abst) 1442Menè P, Pugliese F, D'Agostino A, Cinotti GA: Throm-

boxane A2, prostaglandins, and mesangial cellproliferation 554

Mento PF See Wilkes BM et al 992Merlino C (abst) 1439Merriweather C (abst) 490Messent JWC, Elliott TG, Hill RD, iarrett R.J, Keen H,

Viberti GC: Prognostic significance of microalbumin-uria in insulin-dependent diabetes mellitus: A twenty-three year follow-up study 836

Messineo L (abst) 1443Metsärinne K (abst) 499Meyer X (abst) 490Meyer-Lehnert H See Kramer HJ et al 36:S-2Meyers C See Heeger P et al 220Meyrier A See Mal F et al 445Michael A (abst) 704Michael AF See Kieppel MM et al 1629Michel i-B See Anidjar S et a! 37:S-61Michinaga I See Ogahara S et al 175Middleton JP See Collins DM Ct al 1292Miettinen A (abst) 696Mihatsch Mi (abst) 483, 491, 495, 1445Milan M See Ronco C et a! 1383Miller D See Nakamura T et a! 1213Miller LG See Choyke PL et al 1595Miller TE, Findon G, Rainer SP, Gavin JB: The pathol-

ogy of subclinical pyelonephritis—An experimentalevaluation 1356

Mimran A, Ribstein i, Jover B: Aging and sodiumhomeostasis 37:S-107

Mimura N See Ohashi K et a! 1646Mm L (abst) 697Mm MG (abst) 1453Minson i See Arnolda L et a! 37:S-2Minuth WW, Dermietzel R, Kloth 5, Hennerkes B: A

new method culturing renal cells under permanentsuperfusion and producing a luminal-basal mediumgradient (Technical Note) 215

Minutolo R (abst) 1445Mion CM See Kerr PG et a! 1035Mir S (abst) 1467, 1468, 1471Mitchell KD See Carmines PK et a! 36:S-43Mittermair C (abst) 698Miura AB See Komatsuda A et al 1204Mjornstedt L (abst) 509Mocan H (abst) 1471Mocciaro A (abst) 1439Mogensen CE See Damsgaard EM et a! 731Mogensen CE See Hansen KW et a! 847Mogensen CE See Mauer M et a! 717Mogensen CE See Pederson MM et a! 883Mohaupt M See Kramer HJ et al 36:S-2Molenaar iC (abst) 1437Molitoris BA: The potential role of ischemia in renal

disease progression 36:S-2!Moliz M (abst) 695Moll R (abst) 489Monga G (abst) 1447Monnens LAH (abst) 1430Montanan A (abst) 1445Moon C (abst) 1458, 1459, 1459Moon CO (abst) 1450, 1450, 1451, 1457, 1463Moon DR (abst) 1450Moon HR (abst) 1461Moore KP, Taylor GW, Gove C, Wood J, Tan K-C,

Eason J, Williams R: Synthesis and metabolismof the cysteinyl leukotrienes by the isolated pigkidney 1543

Morabito N (abst) 1444More IAR See Gibson 1W et al 211

Morgan TO, Anderson A: Hemodynamic comparisonsof enalapri! and felodipine and their combination .... 36:S-78

Morganti A (abst) 1446Moriero E (abst) 1443Morigi M (abst) 697Morii H See Shoji T et a! 1653Morioka T (abst) 697MØrkrid L See Ofstad i et al 36:S-8Moromisato R See Nayak RC et al 1638Morozumi K (abst) 1445Morrissey i See Yanagisawa H et a! 1000Morton JJ See Lever AF et a! 37:S-51Moscatelli P (abst) 1446Mosconi L See Gaspari F et a! 1081Motz W (abst) 487Moudry-Munns KC See Cheung AHS et a! 924Mukhtar A (abst) 703MUller CA (abst) 489, 489Muller GA (abst) 482, 489, 489, 495, 703Muller GY, Zabaleta ME, Arminio A, Colmenares Ci,

Capriles Fl, Bianco NE, Machado IV: Risk factorsfor dialysis-associated hepatitis C in Venezuela 1055

Muller M (abst) 489Muller S (abst) 495Muller V (abst) 498MUller-Ruchholtz W (abst) 488Mullins J See Bachman S et al 24Mullins ii See Barrett GL et a! 37:S-l25MUlsch A (abst) 697Munaut C (abst) 700Munck 0 (abst) 508Mundel P (abst) 489Muollo B See Fioretto P et al 813Muthny FA (abst) 488


Mutti A See Khalil-Manesh F et a! 1192Myers BD See Scandling JD et al 840Myers JC See Alvarez RJ et a! 14Nadasdy T See Neufeld TK et a! 1222Nafz B (abst) 490Nagata M See Sakai T et al 533Nahas AME: Growth factors and glomerular

sclerosis 36:S-15Nahman NS Jr., Leonhart KL, Cosio FG, Hebert CL:

Effects of high glucose on cellular proliferation andfibronectin production by cultured human mesangialcells 396

Naito S See Ogahara S et al 175Najarian JS See Cheung AHS et a! 924Nakada J See Nosaka K et al 73Nakamoto Y See Komatsuda A et al 1204Nakamura T, Miller D, Ruoslahti B, Border WA: Pro-

duction of extracellular matrix by glomerular epithe-hal cells is regulated by transforming growthfactor-/31 1213

Nakamura Y See Sakamoto H et a! 350Nakazato Y See Sedor JR et al 595Nankivell BJ, Fawdry RM, Harris DCH: Assessment of

glomerular filtration rate in small animals by intra-peritoneal 99mTc DTPA (Technical Note) 450

Napodano P (abst) 1447, 1447Narita I (abst) 697Nasini MG (abst) 1441

Nassberger L (abst) 507Nast CC (abst) 700, 705Nast CC See Ihm C-G et al 768Natochin Y (abst) 478Navar LG See Carmines PK et al 36:S-43Nayak RC, Attawia MA, Cahill CJ, King GL, Ohashi

H, Moromisato R: Expression of a monoclonal anti-body (3G5) defined ganglioside antigen in the renalcortex 1638

Neild GH (abst) 695Neilson EG See Alvarez RJ et al 14Neilson EG See Heeger P et a! 220Neufeld TK, Douglass D, Grant M, Ye M, Silva F, Na-

dasdy T, Grantham JJ: In vitro formation and expan-sion of cysts derived from human renal cortex epithe-ha! cells 1222

Neumayer H-H, Kunzendorf U, Schreiber M: Protec-tive effects of calcium antagonists in human renaltransplantation 36:S-87

Neusser M (abst) 495Newman GE See Collins DM et a! 1292Ng LL, Davies JE: Lipids and cellular Na/H antiport

activity in diabetic nephropathy 872Nicolosi G See Trevisan R et al 855Niederreither K (abst) 706Nielsen B (abst) 505, 506Nielsen B See Parving H-H et a! 758Nielsen EM (abst) 511Nielsen F (abst) 506Nielsen PK (abst) 501, 502, 509Nielsen SL (abst) 505Njhei H See Ohashi K et a! 1646Niimi K See Santos F et al 356Nishi S See Hayashi H et al 749Nishitani H See Shoji T et al 1653Nishizawa Y See Shoji T et al 1653Nobiling R (abst) 479, 696Nobiling R See Sakai T et al 533

Noble NA See Border WA et a! 566Nogués X See SentI M et al 1394Noh JW (abst) 1452, 1452Noland TD See Takeda M et al 1713Norby A (abst) 500Nord CE (abst) 503Nordal KP (abst) 500, 509Nordén G (abst) 509Nord!ander M, Havu N: Effects of chronic felodipine

treatment on renal function and morphologyin SHR 36:S-100

Nordlander M See DiBona GF et al 36:S-1Nordlander M See Elmfeldt D et at 36:S-54NØrgaard K See Borch-Johnsen K et al 719Noronha IL (abst) 480, 490, 497, 700Nosadini R See Fioretto P et a! 813Nosadini R See Trevisan R et al 855Nosaka K, Nakada J, Endou H: Cisplatin-induced alter-

ations in renal structure, ammoniagenesis and gluco-neogenesis of rats 73

Nouwen EJ (abst) 1435Novarini A (abst) 1445Nussenblatt R See Choyke PL et a! 1595Nutting CW, Islam S, Ye M, Batile DC, Daugirdas JT:

The vasorelaxant effects of acetate: Role of adeno-sine, glycolysis, lyotropism, and pH, and Ca2 166

Nyberg G (abst) 509, 703Nylanden P (abst) 508Nystrand R (abst) 501Oberle G (abst) 495Oberleithner H (abst) 497Obrant K (abst) 507O'Brien RC See Cooper ME et al 898Ocal G (abst) 1471O'Dea F See Barrett BJ et a! 1274O'Donoghue DJ See Brenchley PB et al 933Oe LP See Kouw PM et al 440Oe PL (abst) 1438Oehring H (abst) 482Oemar BS (abst) 697O'Farrell SC See Heeger P et al 220Ofstad J, Horvei G, Kvam Fl, MØrkrid L, Sekse I,

Svarstad E, Iversen BM: Glomerular hemodynamicsin progressive renal disease 36:S-8

Ogahara S, Naito S, Abe K, Michinaga I, Arakawa K:Analysis of HLA class II genes in Japanese patientswith idiopathic membranous glomerulonephritis 175

Ogilvie A (abst) 490, 698Ogino S See Hayashi H et a! 749Ogura Y See Ohashi K et al 1646Oh DJ (abst) 1455, 1455Oh HY (abst) 1450, 1452Oh MS (abst) 1450Ohashi H See Nayak RC et a! 1638Ohashi K, Hara M, Kawai R, Ogura Y, Honda K, Ni-

hei H, Mimura N: Cervical discs are most susceptibleto beta2-microg!obulin amyloid deposition in the ver-tebral column 1646

OiteT(abst) 697Oko A (abst) 488Okten A (abst) 1471Olausson M (abst) 509O!bricht CJ, Geissinger B, Gutjahr E: Renal hypertro-

phy in streptozotocin diabetic rats: Role of proteo-lytic lysosomal enzymes 966

Ølgaard K (abst) 501, 501, 502, 508, 509, 512


Olgemoller B (abst) 705Olivieri 0 (abst) 1446Oliviero P See BeuveCs et a! 37:S-45Olthof CG See Kouw PM et a! 440Omboni S See Parati G et a! 37:S-24Onat 0 (abst) 1469O'Neil LAJ: How does interleukin-1 activate cells7 546Onen K (abst) 1466, 1466, 1467Oozma G (abst) 1472Opocher G See Fioretto P et al 813Oreopoulos DG See Breborowicz A et a! 1280Ørskov H See Flyvbjerg A et al 805Orzincolo C (abst) 1441Osborne-Pellegrin M See Anidjar S et a! 37:S-61Østerby R (abst) 703Østerby R See Walker JD et al 741Ostman A See Heldin C-H et a! 571Ostrow B See Tilton RG et al 778Ott! I (abst) 496Oudar 0 See Shahedi M et al 455Owens DR See Vora JP et al 829Oz H (abst) 1467Ozaip A (abst) 1471Ozcebe 0 (abst) 1470, 1471, 1472Ozdamar K (abst) 1467OzdemirO(abst) 1470, 1471, 1472Ozdemir Y (abst) 1469Ozdogan E (abst) 1466, 1473Ozener (abst) 1470OzgozUkara A (abst) 1467OzgUn S (abst) 1470Paape ME (abst) 1431Padalino PK See Koenig KG et a! 161Padovese P (abst) 1443Pai KS (abst) 1453Paillard M See Houillier P et al 1182Palazzi P (abst) 1439Pallone TL, Hyver SW, Petersen J: A model of the vol-

umetrically-controlled hemodialysis circuit 1366Pals SL (abst) 1438Pancham R (abst) 1431Panitz H (abst) 488Panzetta G (abst) 1446Paoletti E (abst) 1443Paolini F (abst) 1446Parati G, Omboni S, Di Rienzo M, Frattola A, Albini

F, Mancia G: Twenty-four hour blood pressure vari-ability: clinical implications 37:S-24

Parenti M (abst) 1439Parfrey PS See Barrett BJ et al 1274Park CG (abst) 1450Park C-H (abst) 1448, 1449, 1460, 1460Park CJ (abst) 1460Park CS (abst) 1455Park CW (abst) 1460Park HC (abst) 1449, 1460, 1465Park I(abst) 1463Park IS (abst) 1448, 1455, 1464, 1464, 1465Park JK (abst) 702, 1452, 1462

Park JS (abst) 1450, 1458

Park KK(abst) 1453

Park MCH (abst) 1465

Park MH (abst) 1452

Park MI (abst) 1457

Park MS (abst) 1458, 1459, 1459

Park SB (abst) 1453, 1458, 1460

Park SE (abst) 1457, 1461, 1461

Park SH (abst) 1464

Park SJ (abst) 1457

Park S-K (abst) 1448, 1450, 1458

Park Y-H (abst) 1460, 1465

Park YS (abst) 1451, 1451, 1451

Parks JR See Coe FL et a! 139

Parlongo S (abst) 1442, 1443

Parving H-H, Gall M-A, SkØtt P, JØrgensen HE, LØk-

kegaard H, JØrgensen F, Nielsen B, Larsen S: Preva-lence and causes of albuminuria in non-insulin-depen-dent diabetic patients 758

Parving H-H See Borch-Johnsen K et a! 719Patrono C See Remuzzi G et al 1483Paul M (abst) 496Pavenstädt H (abst) 698Pedersen E (abst) 505, 508, 508Pedersen EB, SØrensen SS, Eiskjr H, Skovbon H,

Thomsen K: interaction between cyclosporine andfelodipine in renal transplant patients 36:S-82

Pedersen RS (abst) 510Pederson MM, Hansen KW, Schmitz A, SØrensen K,

Christensen CK, Mogensen CE: Effects of ACE inhi-bition supplementary to beta blockers and diuretics inearly diabetic nephropathy 883

Pederson MM See Hansen KW et a! 847Pedro-Botet J See SentI M et al 1394Pedrotti A, Bonjour J-P, Guignard J-P: Protection from

hypoxemia-induced renal dysfunction by the thio-phosphate WR-2721 80

Pehrsson SK (abst) 504Pei Y, Hercz G, Greenwood C, Sherrard D, Segre G,

Manuel A, Saiphoo C, Fenton 5: Non-invasive pre-diction of aluminum bone disease in hemo- and pen-toneal dialysis patients 1374

PelegrI A See SentI M et al 1394Peltenburg HG See Kooman JP et al 1041Penninckx R See Soupart A et al 1662Perfumo F See Canepa A et a! 1016Perico N See Gaspari F et a! 1081Perier 0 See Soupart A et al 1662Perinotto P (abst) 1445Perrone RD: Means of clinical evaluation of renal dis-

ease progression 36:S-26Persson B See Rudberg S et a! 822Persson I-B (abst) 512Persson PB (abst) 481, 490Peters J See Bachman S et a! 24Peters JR See Vora JP et a! 829Petersen J See Pallone TL et a! 1366Petersen K (abst) 486Petrarulo M (abst) 1445Petrini C (abst) 1445Petruccelli D See Fernández JM et a! 1029Pettersson E (abst) 504Pfaller K (abst) 497Pfaller W (abst) 497Pfeiffer C (abst) 705Pfeilschifter J (abst) 490, 491, 697Phan SR (abst) 1452Philippe C See Baud L et a! 600Piazza V (abst) 1443Picardi L (abst) 1443Piccoli G (abst) 1442, 1442Pilowsky P See Arnolda L et a! 37:S-2Pinerolo C (abst) 697


Pinto J See Jones SL et at 1620Pippin J See Reyes AA et al 100Pisetsky DS See Spurney RF et at 973Pizzonia JH (abst) 485Poggio F (abst) 1443Poletti LF See Santos F et a! 356Ponticelli C (abst) 1446Pontoriero G (abst) 1444Pooth U (abst) 483Porn MT (abst) 1447, 1447Post M (abst) 701Postma CT (abst) 1436Postorino M (abst) 1443

Pouyssegur J (abst) 485Povisen JV (abst) 506, 509Power DA (abst) 699, 703, 703, 706Power DA See Batlmer PE et at 132Pozzi C (abst) 1442Preisig R See Schaad HJ et at 420Pnigent A See Houillier P et a! 1182Prins F (abst) 700Pritzl P (abst) 701Pritzl P See Floege J et a! 297Privitera M (abst) 1444Proctor RK See Collins DM et al 1292Provoost AP (abst) 1437PrUtz K (abst) 506Pugliese F (abst) 1442Pugliese F See Menè P et a! 554Pugliese G See Ido Y et at 435Pusey CD (abst) 704Pusey CD See Spencer SJW et at 1059Pussard E See Berdeaux A et at 37:S-29Pyun K-H (abst) 1453Quamme GA: Free cadmium activity in renal epithelial

cells is enhanced by Mg2+ depletion 1237Quan ZY, Watser M, Hill GS: Adrenalectomy amelio-

rates ablative nephropathy in the rat independently ofcorticosterone maintenance level 326

Quarello F (abst) 1442Quarto Di Palo F (abst) 1439Quednau B (abst) 494Raasveld MHM (abst) 1438Raatz SK See Satahudeen AK et at 183Rabbia C (abst) 1439Rabelink AJ (abst) 1436Radeke HH (abst) 698Radermacher J, Klanke B, Schurek H-J, Stolte HF,

Frolich JC: Importance of NO/EDRF for gtomerularand tubular function: Studies in the isolated perfusedrat kidney 1549

Radice A (abst) 1442Radounikli A (abst) 491Raffelsiefer A (abst) 478Raiftery M See Walker JD et al 741Raghunath M (abst) 489Ragni G (abst) 1445Ragunath M (abst) 483Rahilly MA (abst) 701Rahn KH (abst) 478, 493, 495Raij L See Tolins JP et a! 1254Rainer SP See Miller TE et al 1356Rakhit A See Smith SR et al 199Rambausek M (abst) 497, 498

Ramboer I, Bun P, Lacape G, Daret D, LamaziereJ-MD, Larrue J: Effects of monohydroxylated fattyacids on arterial smooth muscle cell properties 37:S-67

Ramirez G, Saba SR, Dietz JR, Vesely DL: Immuno-cytochemical localization of proANF 1-30, proANF3 1-67, and atnial natriuretic factor in the kidney 334

Rannou F See Beuve CS et at 37:S-45Rasmussen HH (abst) 511Rasmussen K (abst) 502, 508, 508, 509Rasmussen KC (abst) 508Rasmussen LS (abst) 502Rassier ME, McIntyre Si, Yamaki M, Takeda S,

Lin J-T, Dousa TP: Isozymes of cyclic-3', 5'-nucleo-tide phosphodiesterases in renal epithelial LLC-PK1cells 88

Ratcliffe PJ (abst) 481Ratctiffe PJ See Tan CC et al 1581Rauterberg EW (abst) 492Reboucas NA (abst) 485Reddy R See Barrett BJ et al 1274Redlak M (abst) 494Rees AJ (abst) 704Rees AJ See Spencer SJW et a! 1059Reichel H (abst) 491Reilly RR (abst) 485Rekola S (abst) 511, 511Relander A (abst) 505Remuzzi A (abst) 697Remuzzi G (abst) 697Remuzzi G, FitzGerald GA, Patrono C: Thromboxane

synthesis and action within the kidney (EditorialReview) 1483

Remuzzi G See Fioretto P et al 813Remuzzi G See Gaspari F et a! 1081Renner EL See Schaad HJ et at 420Rennke HG See Anderson S et al 891Repp H (abst) 486, 487Resch K (abst) 698Resnick L See Green DF et al 956Ressem L (abst) 500Reyes AA, Lefkowith J, Pippin J, Klahr S: Role of

the 5-lipooxygenase pathway in obstructivenephropathy 100

Reyes AA, Martin D, Settle S. Klahr S: EDRF role inrenal function and blood pressure of normal rats andrats with obstructive uropathy 403

Rha SY (abst) 1456Rhee SK (abst) 1448, 1451Ribstein J See Mimran A et al 37:S-l07Riedel E (abst) 494Riehi J (abst) 493Riesco A (abst) 695Rifici V See Gupta S et at 1161Ringoir S See Vanholder R et at 1707Rippe B See Haraldsson BS et al 310Risler T (abst) 489, 495Risler T See Erley CM et at 1297Ritz E (abst) 478, 479, 485, 486, 488, 491,

496, 496, 496, 497, 498Rivolta R (abst) 1439Rizza V (abst) 1445Rob PM (abst) 491Roberts AB, McCune BK, Sporn MB: TGF-/3: Regula-

tion of extracetlular matrix 557Robertz-Vaupel C-M (abst) 480Robey PG See Kopp JB et at 56


Robinson RR: From the President: The InternationalSociety of Nephrology and Its Congresses 930

Rocco MV, Chen Y, Goldfarb 5, Ziyadeh FN: Elevatedglucose stimulates TGF/3 gene expression and bioac-tivity in proximal tubule 107

Rodela H See Breborowicz A et al 1280Rodemann HP (abst) 482, 702, 703Rodemann HP See Woithuis A et a! 124Rodriguez-Puyol D (abst) 698Rodriguez-Puyol M (abst) 698Roggendorf M (abst) 483Roh JW (abst) 1450Rolla D (abst) 1443Romano U (abst) 1445Rombolà G (abst) 1441Romero J (abst) 491Romero R See SentI M et a! 1394Ronco C, Brendolan A, Feriani M, Milan M, Conz P,

Lupi A, Berto P, Bettini MC, Greca GL: A new scm-tigraphic method to characterize ultrafiltration in hol-low fiber dialyzers 1383

Ronco P See Stefanovië V et a! 1571Rootwelt K (abst) 500Rosen VJ See Khalil-Manesh F Ct al 1192Rosenberg ME See Correa-Rotter R et al 796Rosenberg ME See Correa-Rotter R Ct a! 938Rosenberg ME See Salahudeen AK et al 183RosenlOf K (abst) 499Rosenzweig SA (abst) 697Rossi M (abst) 1446ROssner S (abst) 503Rother K (abst) 496Rothlein R, Wegner C: Role of intercellular adhesion

molecule-i in the inflammatory response 617Rotunno M (abst) 1439Rouch AJ, Whitford GM, Campbell HT: Fluoride flux

in the rabbit CCD: A pH-dependent event 342Roy-Chaudhury P (abst) 699Roy-Chaudhury P See Balimer PE et al 132Rubiés-Prat J See SentI M et a! 1394Rudberg S, Persson B, Dahiquist G: Increased glomeru-

lar filtration rate as a predictor of diabetic nephrop-athy—An 8-year prospective study 822

Ruef C See Coleman DL et a! 604Ruffet M See Charra B et al 1286Ruggenenti P See Gaspari F et a! 1081Ruiz P See Spurney RF et a! 973Rumble JR See Cooper ME et al 898Rump LC (abst) 491Ruoslahti E See Nakamura T et al 1213Rupprecht HD (abst) 698Russo D (abst) 1445Russo R (abst) 1446Ryall RL See Grover PK et al 149Ryan US See Green DF et a! 1506Rybczyñska A (abst) 492Saatci U (abst) 1470, 1470Saba SR See Ramirez G et a! 334Sabadini E (abst) 1445, 1447, 1447Sachs C See Shahedi M et al 455Sadler R See Bakris GL et al 912Sa1amer L (abst) 1467Said R, Hamzeh Y, Said S, Tarawneh M, A1-Khateeb

M: Spectrum of renal involvement in familial Medi-terranean fever 414

Said S See Said R et a! 414

Sainio K (abst) 696Saiphoo C See Pei Y et a! 1374Saitou T See Hayashi H et al 749Sakai T, Lemley Ky, Hackenthal E, Nagata M, Nobil-

ing R, Kriz W: Changes in glomerular structure fol-lowing acute mesangial failure in the isolated per-fused kidney 533

Sakamoto H, Sasaki 5, Nakamura Y, Fushimi K,Marumo F: Regulation of endothelin-1 production incultured rat mesangial cells 350

Sala MR (abst) 1446Salahudeen AK, Hostetter TH, Raatz SK, Rosenberg

ME: Effects of dietary protein in patients withchronic renal transplant rejection 183

Salit M (abst) 1441Salmonson T (abst) 500, 504, 504Salnitro F (abst) 1444Sa!vadeo A (abst) 1443Samuelsson 0 (abst) 499San A (abst) 1472, 1473Sandberg SM See Ciresi DL et al 1599Sandgren H (abst) 506Sandhagen B (abst) 506Sandrini S (abst) 1440, 1440Sandstrom Di See Anderson S et a! 891Sandvik L See Dahl-JØrgensen K et al 920Sanfihippo F See Spurney RF et al 973Sanna G (abst) 1447Santoro A (abst) 1446Santos F, Chan JCM, Krieg RJ, Niimi K, Hanna JD,

Welions MD, Poletti LF: Growth hormonesecretion from the pituitary cells in chronic renalinsufficiency 356

Sardet C (abst) 485Sariyar M (abst) 1466Sarsmaz N (abst) 1467Sasaki S See Sakamoto H et al 350Sassard J See Barrès C et a! 37:S-19Savi!l i (abst) 704Savill J: Apoptosis: A mechanism for regulation of the

cell complement of inflamed glomeruli 607Savolainen Mi See Hörkkö S et al 1175Sawada S See Lemoine R et al 65Scaini P (abst) 1440, 1440Scandling JD, Myers BD: Glomerular size-selectivity

and microalbuminuria in early diabetic glomerulardisease 840

Schaad Hi, Frey BM, Renner EL, Preisig R, Frey FJ:Microsomal liver function declines steadily after kid-ney grafting: A three to five year follow-up 420

Schaefer RM (abst) 704Schafer JA, Hawk CT: Regulation of Na channels in

the cortical collecting duct by AVP and mineralocor-ticoids (Editorial Review) 255

S chaffer AV See Smith SR et al 199Schalekamp MADH (abst) 1437Schalkwijk I (abst) 1430Schambelan M See Al-Uzri A et al 1701

Schellenberg A (abst) 492Scherberich JE (abst) 479, 488, 492, 492, 498Scherberich I (abst) 486Scheuermann E (abst) 479, 498Scheyerl F (abst) 495, 495Schild C (abst) 481Schimpf BA See Zager RA et al 1588Schindler R (abst) 481, 698


Schirop T (abst) 486Schleicher E (abst) 705Schlipkoter U (abst) 483Schiondorif D See Gupta S et at 1161Schiondorif D See Wilkes BM et a! 992Schlottmann K (abst) 492SchlUter H (abst) 493Schmiedeke T (abst) 495Schmitt H (abst) 483, 493Schmitz A See Pederson MM et at 883Schmouder RL, Strieter RM, Wiggins RC, Chensue

SW, Kunkel SL: In vitro and in vivo interleukin-8production in human renal cortical epithelia 191

Schneider H See Kouw PM et al 440Schneider M (abst) 488Schoeppe W (abst) 479, 483, 483, 491, 492, 492,

495, 497, 498, 696Schollmeyer P (abst) 489, 491, 698Schollmeyer PJ (abst) 479Scholz H (abst) 493Schongen N (abst) 493Schoots AC (abst) 1433Schrama E (abst) 1432Schrama YC (abst) 1433Schramek H (abst) 497Schreiber A (abst) 491Schreiber M See Neumayer H-H et at 36:S-87Schreiner GF See Takahashi K et al 1245Schrier RW (abst) 699Schrier RW See Almeida ARP et a! 1494Schrier RW See Hensen J et at 1333Schroder K See Hensen J et a! 1333Schroijen VJHM (abst) 1432Schubert I (abst) 492Schulze-Lohoff E (abst) 490, 698Schurek H-J See Radermacher J et at 1549Schuster MJ (abst) 491Schwaabe S (abst) 705Schwab SJ See Collins DM et al 1292Schwertfeger E (abst) 491Schwietzer G (abst) 483, 497Schwoerbel C (abst) 492Scigalla P (abst) 496Scotari F (abst) 1440, 1440Sedor JR. Nakazato Y, Konieczkowski M: Interteu-

kin-i and the mesangial cell 595Segagni S (abst) 1443Segoloni GP (abst) 1439, 1439Segre G See Pei Y et a! 1374Seifert RA See Flôege S et al 297Sekse I See Ofstad S et al 36:S-8Setcuk Y (abst) 1473Selvi A (abst) 1440Semplicini A See Trevisan R et al 855SentI M, Romero R, Pedro-Botet 5, PelegrI A, Nogués

X, Rubiës-Prat J: Lipoprotein abnormalities in hyper-lipidemic and normolipidemic men on hemodialysiswith chronic renal failure 1394

Sepe V (abst) 1445Sepe V See Canton AD et al 951Serdengeçti K (abst) 1466, 1466Serventi M (abst) 1445Setenay Dincer K (abst) 1467Setti G (abst) 1440, 1440Settle S See Reyes AA et al 403Sever L (abst) 1467, 1467

Sever M (abst) 1471Sever MS (abst) 1466, 1473Sewing KF (abst) 487Shahedi M, Laborde K, Lelongt B, Oudar 0, Sachs C:

A cytochemical procedure for &termination ofNa,K-ATPase activity in MDCK cells (TechnicalNote) 455

Shan Z See Gupta S et al 1161Shanley PF See Ford DM et al 1606Shapiro SI See Hiatt WR et al 1613Sharma A (abst) 704Shaw S (abst) 481, 493Sherrard D See Pei Y et at 1374Shibata T See Lernoine R et al 65Shimada H See Lemoine R et at 65Shimizu F (abst) 697Shin HS (abst) 1459Shin JH (abst) 1448Shin SH (abst) 1448, 1451Shin YT (abst) 1448, 1451Shoji T, Nishizawa Y, Nishitani H, Yamakawa M,

Morii H: Impaired metabolism of high density tipo-protein in uremic patients 1653

Short CD See Brenchley PE et at 933Sick H (abst) 484Sicuso C (abst) 1442Sidoti A (abst) 1445Sieberth H-G (abst) 482, 483, 493Sieberth H-G See Ittel TH et at 1340Siegbahn A See Heldin C-H et at 571Siems W (abst) 494Siffert W (abst) 494Silomon JF (abst) 483Silva F See Neufeld TK et at 1222Simon SM See Freyss-Beguin MM et a! 37:S-79Simon T See Choyke PL et al 1595Simonsen 0 (abst) 504Simonson MS, Jones JM, Dunn MJ: Cytosolic and nu-

clear signaling by endothelin peptides: Mesangial re-sponse to glomerular injury 542

Sinaz A (abst) 1472Sindel S (abst) 1472Singhal PC, Gibbons N, Abramovici M: Long term ef-

fects of morphine on mesangial cell proliferation andmatrix synthesis 1560

Sinico RA (abst) 1442, 1447, 1447Sisson-Ross S See Vernier RL et at 1070Sixma ii (abst) 1436Sjogren B (abst) 510Skaarup P (abst) 508Skietbo M (abst) 505Skietboe M (abst) 505Skøtt P See Parving H-H et a! 758Skovbon H See Pedersen EB et at 36:S-82Skrasting A (abst) 493Skroch D (abst) 495Slayman CW (abst) 485Slikkerveer A (abst) 1432Stuiter HE See Frenken LAM et at 384Sluiter HE See Huysmans FTM et at 36:S-106Sluiter HE See van Hamersvelt HW et a! 36:S-73Smet RD See Vanholder R et al 1707Smith SR, Creech EA, Schaffer AV, Martin LL, Rakhit

A, Douglas FL, Kiotman PE, Coffman TM: Effectsof thromboxane synthase inhibition with CGS 13080in human cyclosporine nephrotoxicity 199

Author index: Vol. 41 1769

Smith SR See Tilton RG et a! 778Smits P (abst) 1436Smogorzewski M See Chervu I et a! 1501Sohn SH (abst) 1453, 1456, 1458, 1458, 1459, 1463, 1463Solbu D (abst) 507Soleimani B See Esnault VLM et al 1304Soliani F (abst) 1441Son HS (abst) 1454Sone M (abst) 494Song JS (abst) 1455, 1455Sonmez G (abst) 1472Sonsuz A (abst) 1466SØrensen JP (abst) 502SØrensen K See Pederson MM et al 883SØrensen SS See Pedersen EB et al 36:S-82Sorokin L, Ekblom P: Development of tubular and gb-

merular cells of the kidney 657Soupart A, Penninckx R, Stenuit A, Perier 0, Decaux

G: Treatment of chronic hyponatremia in rats by in-travenous saline: Comparison of rate versus magni-tude of correction 1662

Soylemezogtu 0 (abst) 1470, 1470Späth M (abst) 698Spencer SJW, Burns A, Gaskin G, Pusey CD, Rees AJ:

HLA class II specificities in vasculitis with antibodiesto neutrophil cytoplasmic antigens 1059

Spongano M (abst) 1446Sporn MB See Roberts AB et a! 557Spring J (abst) 701Spurney RF, Fan P-Y, Ruiz P, Sanfihippo F, Pisetsky

DS, Coffman TM: Thromboxane receptor blockadereduces renal injury in murine lupus nephritis 973

Sredni B See Gafter U et a! 143Stahl RAK (abst) 483, 483, 491, 495, 696Steen Olsen T (abst) 499, 508Stefani A (abst) 1441Stefanovië V, Vlahovië P, Ardaillou N, Ronco P, Ar-

dailbou R: Cell surface aminopeptidase A and N ac-tivities in human glomerular epithelial cells 1571

Steffensen U (abst) 506Steffes MW See Lane PH et a! 1085Steffes MW See Mauer SM et a! 736Steffes MW See Vernier RL et a! 1070Steffgen J (abst) 494, 495, 495Stegeman CA (abst) 1435Stegmayr B (abst) 502, 506Stehouwer CDA (abst) 1433Stein G (abst) 482Steinhauer HB (abst) 489Steinhausen M (abst) 492Stentoft J (abst) 511Stenuit A See Soupart A et al 1662Stenver D (abst) 505, 506Stenvinkel P (abst) 503Sterzel RB (abst) 490, 698, 698Sterzel RB See Kashgarian M et a! 524Sterzel RB See Madri JA et at 523Stock! F (abst) 495Sto!te HF See Radermacher J et al 1549Stone BG See Tolins JP et al 1254Stone E See Barrett BJ et al 1274Störkel S (abst) 492Storm T (abst) 503Strandgaard S (abst) 499, 508Strate M (abst) 510Stratta P (abst) 1447

Strauer BE (abst) 487Streefland C (abst) 1437Streekstra G (abst) 1436Strieter RM (abst) 695Strieter RM See Schmouder RL et a! 191StrOmbom U (abst) 511Stroomer MKJ (abst) 1437Struijk DG (abst) 1436Struijk DG, Koomen GCM, Krediet RT, Arisz L: Indi-

rect measurement of lymphatic absorption in CAPDpatients is not influenced by trapping 1668

Strutz F (abst) 495Struyker-Boudier HAJ See Kooman JP et a! 1041Sucak U (abst) 1472Sudhir K See Angus JA et a! 37:S-73Suk CW (abst) 1456Sukhatme VP (abst) 698Sukhatme VP: The Egr transcription factor family:

From signal transduction to kidney differentiation 550SUkrU Sever M (abst) 1467Sun MJ See Alvarez RI et a! 14Sun MJ See Heeger P et a! 220Sun X (abst) 1438Sung KH (abst) 1449, 1460, 1465Sung KT (abst) 1449Sungur C (abst) 1469, 1471, 1472Sutherland DER See Cheung AHS et al 924Sutherland DER See Mauer SM et al 736Suzuki Y See Hayashi H et a! 749Svaland M (abst) 500Svalander C (abst) 511Svarstad E See Ofstad J et a! 36:S-8Swynghedauw B See Beuve CS et a! 37:S-45Symreng T, F!anigan MJ, Lim VS: Ventilatory and

metabolic changes during high efficiency hemo-dialysis 1064

Szczepañska-Konkel M (abst) 494Szewczyk Z (abst) 487Takahashi K, Kato T, Schreiner GF, Ebert J, Badr KF:

Essential fatty acid deficiency normalizes functionand histology in rat nephrotoxic nephritis 1245

Takeda M, Breyer MD, Noland TD, Homma T, HooverRL, Inagami T, Kon V, Fredin DM, Hellings SE:Endothelin- 1 receptor antagonist: Effects on endothe-un- and cyclosporine-treated mesangial cells 1713

Takeda S See Rassier ME et at 88Tamsma JT (abst) 1432Tan CC (abst) 481

Tan CC, Ratcliffe PJ: Rapid oxygen-dependent changesin erythropoietin mRNA in perfused rat kidney: Evi-dence against mediation by cAMP 1581

Tan K-C See Moore KP et at 1543Taranta A (abst) 1442Tarantino A (abst) 1439Tarawneh M See Said R et al 414Tariq T See Lopes de Faria JB et al 877Tarjan E, Denton DA, Ferraro T, Weisinger RS: Effect

of CRF, ACTH and adrenal steroids on sodium in-take and excretion of rabbits 37:S-97

Taroto G (abst) 1443Tasby J See Truong LD et at 1676Tashima Y See Komatsuda A et al 1204Taskinen E See Isoniemi HM et a! 155Tatlikazan L (abst) 1473Tauber M (abst) 492Taylor GW See Moore KP et al 1543


Telaferli A (abst) 1467ten Berge R.JM (abst) 1438Tepel M (abst) 495ter Wee PM See Kouw PM et at 440Terkildsen K (abst) 511Termine JD See Kopp JB et a! 56Terzlog!u 0 (abst) 1471Teschner M (abst) 704Tevfik Ecder S (abst) 1467Thaiss F (abst) 483, 483, 491, 495, 696Thea A (abst) 1447Thiel G (abst) 498Thiel G See Bock HA et al 275Thien Th (abst) 1436Thoenes W (abst) 489Thomas D See Vora JP et a! 829Thomas GJ See Davies M et a! 671Thomsen K See Pedersen EB et al 36:S-82Thurau K (abst) 494Thysell H (abst) 511Tiengo A See Fioretto P et a! 813Tilocca P (abst) 1447Tilton RG, Baier LD, Harlow JE, Smith SR, Ostrow E,

Williamson JR: Diabetes-induced glomerular dysfunc-tion: Links to a more reduced cytosolic ratio ofNADH/NAD 778

Tilton RG See Ido Y et al 435Timpka T (abst) 502Tinaztepe K (abst) 1466Tiselius H-G (abst) 510Tizianello A (abst) 1446Toback FG: Regeneration after acute tubular necrosis

(Nephrology Forum) 226Tolbert E See Lax DS et al 1527Tolins JP, Stone BG, Raij L: Interactions of hypercho-

lesterolemia and hypertension in initiation of glomer-ular injury 1254

Tomiyama T (abst) 1431Tomooka S See Border WA et a! 566Tonbul HZ (abst) 1472, 1473Topaloglu R (abst) 1470Topley N (abst) 699Törnroth T (abst) 508Torrat J-C See Charra B et al 1286Torre L See Gaspari F et al 1081Travaglini M (abst) 481, 1443Trevisan R, Nosadini R, Fioretto P, Semplicini A, Don-

adon V, Doria A, Nicolosi G, Zanuttini D, CipollinaMR, Lusiani L, Avogaro A, Crepaldi G, Viberti GC:Clustering of risk factors in hypertensive insulin-de-pendent diabetics with high sodium-lithiumcountertransport 855

Trevisan R See Fioretto P et al 813Triolo G (abst) 1439Troschau G (abst) 497Troy JL See Anderson S et a! 891Truong LD, Farhood A, Tasby J, Gillum D: Experi-

mental chronic renal ischemia morphologic and im-munologic studies 1676

Tsai P (abst) 699Tsalamandris C See Jerums G et a! 904Tsapas G See Magoula I et at 1349Tschernko E (abst) 496Tschope W (abst) 496Tsobanelis T (abst) 496Tufve son U (abst) 507

Tufvesson G (abst) 501TUlbek MY (abst) 1468Turner N (abst) 1471

Tuna (abst) 1466, 1473Turgan c (abst) 1469, 1470, 1471, 1472Turner N (abst) 704Tvedt KE (abst) 500Ucci AA See Vlahakos DV et al 1690Ucmakli E (abst) 1468Ueno M See Hayashi H et al 749lJlkü U (abst) 1466, 1466Ulirich KJ (abst) 478, 479, 480Ulrichs K (abst) 488Ulukutlu L (abst) 1467Unlubozkurt M (abst) 1467Usadel K-Fl (abst) 486UsluS(abst) 1467VaaBen W (abst) 482Valpondi P (abst) 1441van Acker BAC (abst) 1437, 1437van Bommel EFH (abst) 1434van Bortel L (abst) 1433van Bortel LMAB (abst) 1434van Bortel LMAB See Kooman JP et at 1041van Buren M (abst) 1434Van De Voorde J (abst) 1432van de Wiel BA (abst) 1431van den Born J (abst) 1432van den Born J, van den Fleuvel LPWJ, Bakker MAH,

Veerkamp JH, Assmann KiM, Berden JHM: Amonoclonal antibody against GBM heparan sulfateinduces an acute selective proteinuria in rats 115

van den Dobbeisteen MEA (abst) 695, 1435van den Heuvel LPWJ See van den Born J et at 115van den Ouweland AMW (abst) 1430van der Horst MLC (abst) 1431van der Hoven B (abst) 1434van der Meulen J (abst) 1438van der Wal A (abst) 1430van der Woude FJ (abst) 695, 1431, 1435van Diemen-Steenvoorde R (abst) 1430van Diepen FNJ (abst) 1438van Es LA (abst) 695, 1431, 1435van Es LA: Pathogenesis of IgA nephropathy (Nephrol-

ogy Forum) 1720van Es PN (abst) 1436van Gompel APM (abst) 1430van Goor H (abst) 1431van Hamersvelt HW, Sluiter HE, Wetze!s JFM,

Koene RAP, Huysmans FTM: Is natriuresis onfelodipine due to reversal of the renal effects ofangiotensin II 36:S-73

van Hamersvelt HW See Huysmans FTM et al 36:S-106van HooffJP (abst) 1433, 1434, 1435van Hooff JP See Kooman JP et a! 1041van Leengoed LAMU (abst) 1434van Olden RW (abst) 1433van Oost BA (abst) 1430van Os CH (abst) 1434van Rooyen N (abst) 1430van Tol A (abst) 1438van Willebrand E See Isoniemi HM et at 155Vane! T See Charra B et al 1286


Vanholder R, Hoefliger N, Smet RD. Ringoir S, Vogel-eere P: Extraction of protein bound ligands fromazotemic sera: Comparison of 12 deproteinizationmethods (Technical Note) 1707

Vanuytsel J (abst) 1433Vasilakakis DM, D'Haese PC, Lamberts LV, Lemonia-

tou E, Digenis PN, Broe MED: Removal of alumi-noxamine and ferrioxamine by charcoal hemoperfu-sion and hemodialysis 1400

Vavasour HM See Barrett BJ et al 1274vd Born J (abst) 1432vd Woude FJ (abst) 1432Veerkamp JH See van den Born Jet al 115Vegeto A (abst) 1439Vehaskari VM See Bonilla-Felix M et a! 1150Veis JH See Berl T et al 37Verbeke M (abst) 1432Vercellone A (abst) 1439, 1439, 1447Vernier RL, Steffes MW, Sisson-Ross 5, Mauer SM:

Heparan sulfate proteoglycan in the glomerular base-ment membrane in type 1 diabetes mellitus 1070

Verstrepen W (abst) 1435Vesely DL See Ramirez G et a! 334Viberti G See Jones SL et a! 1620Viberti GC See Lopes de Faria JB et at 877Viberti GC See Mauer M et a! 717Viberti GC See Messent JWC et a! 836Viberti GC See Trevisan R et al 855Viberti GC See Walker JD et a! 741Viganà E (abst) 1446Viganô G See Gaspari F et a! 1081Villa G (abst) 1443Virotta G See Gaspari F et a! 1081Virtanen I See Korhonen M Ct a! 641Vitale C (abst) 1445Vitulo F (abst) 1444Viahakos DV, Foster MH, Adams S, Katz M, Ucci

AA, Barrett KJ, Datta SK, Madaio MP: Anti-DNAantibodies form immune deposits at distinct glomeru-lar and vascular sites 1690

V!ahovië P See Stefanovi V et a! 1571Vogeleere P See Vanholder R et al 1707Vogt A (abst) 495Voisard R (abst) 483Volkmann R (abst) 500, 512von dem Borne AEGKr (abst) 1431von der Mark H See von der Mark K et a! 632Von der Mark K (abst) 696von der Mark K, von der Mark H, Goodman S: Cellu-

lar response to extracellular matrix 632Vora JP, Dolben J, Dean JD, Thomas D, Williams JD,

Owens DR, Peters JR: Renal hemodynamics in newlypresenting non-insulin dependent diabetes mellitus 829

VosPF(abst) 1435Vosbeck K (abst) 697Vrtovsnik F, El Yandouzi EH, Le Grimellec C, Fried-

lander G: Sphingomyelin and cholesterol modulatesodium coupled uptakes in proximal tubular cells 983

Waaga A-M (abst) 488Wagner C (abst) 496Wagner E (abst) 705Wagner J (abst) 496, 496Wahlberg J (abst) 501, 509Wakai S, Magil AB: Focal glomerulosclerosis in idio-

pathic membranous glomerulonephritis 428Wakui H See Komatsuda A et a! 1204

Waldegger S (abst) 488Waldherr R (abst) 480, 490, 497, 700, 701Walker JD, Close CF, Jones SL, Raiftery M, Keen H,

Viberti GC, Østerby R: Glomerular structure intype-i (insulin-dependent) diabetic patients withnormo- and microalbuminuria 741

Walser M See Quan ZY et al 326Wande! E (abst) 487Waniewski J See Heimburger 0 et a! 1320Wanner C (abst) 698Wantzin P (abst) 502Ward JE See Angus JA et a! 37:S-73Ward RA (abst) 482Warram JH See Barzilay J et a! 723Wasewicz M (abst) 492Watanabe Y, Kashihara N, Makino H, Kanwar YS:

Modulation of glomerular proteoglycans by insulin-like growth factor-i 1262

Waterloos M (abst) 1432Watson H See Bailmer PE et al 132Watson ML, Macnicol AH, Allan PL, Wright AF: Ef-

fects of angiotensin converting enzyme inhibition inadult polycysic kidney disease 206

Webb DR See Coe FL et a! 139Weber BK See Ballmer PE et a! 132Weber M: Basement membrane proteins 620Weber RFA (abst) 1437Weening JJ (abst) 702, 1432, 1432Wegner C See Rothlein R et al 617Wehrle-Haller B (abst) 701Wehrmann M (abst) 484Weidmann P (abst) 481, 493Weidmann P See Blumberg A et al 369Weier S (abst) 492Weinlich M (abst) 1444Weinreich T (abst) 479Weis H (abst) 497Weisberg LS, Kurnik PB, Kurnik BRC: Radiocontrast-

induced nephropathy in humans: Role of renalvasoconstriction 1408

Weisinger RS See Tarjan E et al 37:S-97Weiss H (abst) 488Weiss L (abst) 506Weisstuch JM, Dworkin LD: Does essential hyperten-

sion cause end-stage renal disease9 36:S-33Welcer ER (abst) 699Weller A (abst) 705Wellons MD See Santos F et al 356Wendel 0 (abst) 494Wentzel T (abst) 506Wenzel UO (abst) 497Werle E (abst) 484Werynski A See Heimburger 0 et a! 1320Wessén P (abst) 506Westberg G (abst) 511Westenfelder C (abst) 699Westermark B See Heldin C-H et al 571Westphale H-J (abst) 497Westwick J (abst) 695Wetzels JFM See Almeida ARP et al 1494Wetzels JFM See Elving LD et al 862Wetzels JFM See Frenken LAM et a! 384Wetzels JFM See Huysmans FTM et al 36:S-l06Wetzels JFM See van Hamersvelt HW et a! 36:S-73Wheeler DC (abst) 699Whitford GM See Rouch AJ et a! 342


Whitworth JA: Adrenocorticotrophin and steroid-in-duced hypertension in humans 37:S-34

Widerøe TE (abst) 507Widstam-Attorps U (abst) 512Wiccel A (abst) 488Wieslander J (abst) 511

Wiggins RC (abst) 1452, 1452Wiggins RC See Schmouder RL et al 191Wijnen JAG See Kooman JP et at 1041Wikstom B (abst) 501WikstrOm B (abst) 500, 501, 504, 504, 506, 507, 509WiktrOm B (abst) 512Wilkes BM, Kaplan R, Mento PF, Aynedjian HS, Mac-

ica CM, Schiondorif D, Bank N: Reduced glomerularthromboxane receptor sites and vasoconstrictor re-sponses in diabetic rats 992

Williams JD (abst) 699Williams JD See Vora JP et al 829Williams R See Moore KP et at 1543Williamson JR See Ido Y et at 435Williamson JR See Tilton RG et a! 778Willinger CC (abst) 497Windus DW See Delmez JA et al 1023Winkler D (abst) 481Winther K (abst) 505, 506Wirth S (abst) 481Wirtz C (abst) 478Wiseman M See Jones SL et at 1620Wissmann C (abst) 486Wolf G See Heeger P et al 220WOll E (abst) 488Woithuis A (abst) 702Woithuis A, Boes A, Rodemann HP, Grond J: Vasoac-

tive agents affect growth and protein synthesis of cul-tured rat mesangial cells 124

Woo HJ (abst) 1455Woo JY (abst) 1448, 1464, 1464Wood J See Moore KP et at 1543Woun KK (abst) 1456Woytacha DR (abst) 699Wrigge P (abst) 484Wright AF See Watson ML et at 206Wright CE See Angus JA et at 37:S-73Wunderle W (abst) 484Xiaosheng Y (abst) 1435Yalcinkaya F (abst) 1471Yamac K (abst) 1472Yamakawa M See Shoji T et a! 1653Yamaki M See Rassier ME et at 88Yamamoto T See Border WA et at 566Yamamoto T See Kawasaki K et at 1517Yamaner S (abst) 1471Yanagisawa H, Morrissey J, Yates J, Hayes C, Klahr

S: Protein increases glomerular eicosanoid productionand activity of related enzymes 1000

Yang CW (abst) 1455Yang KH (abst) 1460Yang Sil (abst) 1457, 1461, 1461

Yang WS (abst) 1453

Yaoita E See Kawasaki K et at 1517

Yard BA(abst) 1431Yasavill U (abst) 1469, 1470, 1471, 1472Yates J See Yanagisawa H et al 1000Yavuz M (abst) 1466, 1468Ye M See Neufeld TK et al 1222Ye M See Nutting CW et at 166Yergok YZ (abst) 1468Yi GW (abst) 1448, 1451Yi Y (abst) 1458Yildiz I (abst) 1467Yilmazlar T (abst) 1473Ylänne J See Korhonen M et al 641Yong HS (abst) 1456Yoon J (abst) 1462Yoon JB (abst) 1449, 1449Yoon SA (abst) 1448, 1464Yoon YS (abst) 1448, 1455, 1457, 1460, 1460, 1463,

1464, 1464, 1464, 1464, 1464, 1465

Yoshimura A See Floege J et at 297

Yoshimura A See Johnson R et at 590Yoshioka T, Fogo A, Beckman JK: Reduced activity of

antioxidant enzymes underlies contrast media-in-duced renal injury in volume depletion 1008

Young MF See Kopp JB et at 56Yu SH (abst) 1455, 1455Yurtkuran M (abst) 1466, 1468Zabaleta ME See Muller GY et at 1055Zachariae H (abst) 508Zager RA, Bredl CR, Schimpf BA: Direct amphotericin

B-mediated tubular toxicity: assessments of selectedcytoprotective agents 1588

Zahner G (abst) 483, 696Zanner S (abst) 698Zanussi C (abst) 1439Zanuttini D See Trevisan R et at 855Zaoui P See Himmelfarb J et at 388Zayas MA See Anderson S et a! 891Zeh K (abst) 496Zeier M (abst) 498Zerwekh JE See Koenig KG et at 161Zidek W (abst) 493, 495Ziegler R (abst) 484Zimmerman G (abst) 705Ziyadeh FN See Rocco MV et at 107Zoccali C (abst) 1442, 1443, 1444Zoja C (abst) 697Zucchelli P (abst) 1446Zwaginga JJ (abst) 1436Zweegman S (abst) 1438

author index for volume 41 - core · author index for volume 41 aakhus s (abst) 507 abboud he:...

Documents